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Executive Summary
Screening for Distress in Ambulatory Oncology Patients: The COPE Project
Problem
Approximately 1.6 million new cancer cases are expected to be diagnosed in 2012 
(American Cancer Society, ACS, 2012). Recent studies have found that 20-50% of newly 
diagnosed and recurrent cancer patients demonstrate a significant level of distress (Carlson, 
Waller & Mitchell, 2012; Mitchell et al., 2011; Swanson & Koch, 2010). Unfortunately less than 
half of distressed patients with cancer are identified and referred for psychosocial help (Kadan- 
Lottick, Vanderwerker, Block, Zhang & Prigerson, 2005). Elevated levels of distress in cancer 
patients has been associated with decreased adherence to treatment, difficulty making treating 
decisions, extra medical visits, poorer quality of life, and greater stress for the oncology team 
(Fann, Ell, & Sharp, 2012). The National Comprehensive Cancer Network (NCCN, 2012) 
recommends that all patients be screened for distress at their initial visit, at appropriate intervals, 
and as clinically indicated. Based upon this recommendation, the following evidence-based 
project about the population, intervention, comparison, and outcome (PICO) was developed:
Will oncology patients receiving care in a rural ambulatory infusion center who participate in a 
comprehensive psychosocial assessment program experience a decrease in distress levels?
Purpose
The purpose of this Doctorate of Nursing Practice (DNP) Capstone Project was to 
identify, assess, and refer patients who are experiencing an elevated level of distress as measured 
by the NCCN Distress Thermometer.
Goal
The goal of this project was to decrease the psychosocial distress level in patients 
receiving chemotherapy.
Objective
The primary objective of this evidence-based practice project was to decrease distress in 
oncology patients. The secondary objective was to formally adopt the NCCN clinical practice 
guidelines for distress management in ambulatory oncology patients.
Plan
The NCCN Distress Thermometer (DT) was utilized to measure the distress level of 
ambulatory oncology patients currently receiving chemotherapy in an outpatient infusion center. 
The capstone project received Institutional Review Board approval from Regis University as 
well as the New England Institutional Review Board and met exempt status.
Outcomes and Results
A total of 21 ambulatory oncology patients participated in this project. The majority of 
patients (57%) presented with clinical evidence of moderate to severe distress as evidenced by a 
distress score of >4. Physical problems were the most frequently identified source of distress. 
Data analysis revealed an overall decrease in distress scores. However, there was not a 
statistically significant difference in individual distress scores. The NCCN Distress 
Thermometer facilitated the identification, assessment, and treatment of distress in ambulatory 
oncology patients. As a result of this project, the NCCN Distress Management clinical practice 
guidelines have been formally integrated into routine nursing assessments.
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Problem Recognition and Definition
Approximately 1,638,910 new cancer cases are expected to be diagnosed in 2012 
(American Cancer Society, ACS, 2012). Recent studies have found that 20-50% of newly 
diagnosed and recurrent cancer patients demonstrate a significant level of distress (Carlson, 
Waller & Mitchell, 2012; Mitchell et al., 2011; Swanson & Koch, 2010). Unfortunately less than 
half of distressed patients with cancer are identified and referred for psychosocial help (Kadan- 
Lottick, Vanderwerker, Block, Zhang & Prigerson, 2005). Elevated levels of distress in cancer 
patients has been associated with decreased adherence to treatment, difficulty making treating 
decisions, extra medical visits, poorer quality of life, and greater stress for the oncology team 
(Fann, Ell, & Sharp, 2012). The National Comprehensive Cancer Network (NCCN, 2012) 
recommends all patients be screened for distress at their initial visit, at appropriate intervals, and 
as clinically indicated.
Purpose
The purpose of this Doctorate of Nursing Practice (DNP) Capstone Project was to 
identify, assess, and refer patients who are experiencing an elevated level of distress as measured 
by the NCCN Distress Thermometer.
PICO
The Population, Intervention, Comparison, Outcome (PICO) acronym was utilized as the 
framework to form the practice question and facilitate a systematic review of the literature. 
Population: Oncology patients receiving care in a rural ambulatory infusion center 
Intervention: Implementation of the NCCN Distress Management guidelines 
Comparison: There is no comparison group
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Outcome: Decrease in distress scores as measured by the NCCN Distress Thermometer (DT) 
instrument.
As a result of this Capstone Project, the following PICO question will be answered: Will 
oncology patients receiving care in a rural ambulatory infusion center who participate in a 
comprehensive psychosocial assessment program experience a decrease in distress levels? 
Project Significance, Scope and Rationale
The role of the doctorate-prepared advanced practice nurse is to bring evidence to patient 
care (Zaccagnini & White, 2011). According to Zaccagnini & White (2011), “every advanced 
practice nurse should be a nurse scientist, gathering evidence at the patient’s side, making 
observations, having experiences, responding to the patient’s experiences, and thinking about 
reasons, theories, or concepts that might organize the evidence” (p.8). In order to reduce the 
burden of cancer and treatment-related suffering, the author felt it was imperative to implement 
an evidence-based, interdisciplinary clinical practice guideline that will address the psychosocial 
needs of oncology patients. In 2008, the Institute of Medicine (IOM) recommended effective 
psychosocial care be an integral part of quality cancer care. The committee specifically 
recommended the use of tools and strategies to improve patient-provider communication; 
facilitate the identification and assessment of psychosocial health problems, and to design illness 
and wellness management strategies (IOM, 2008).
Theoretical Foundation
Kolcaba (2010) provided a unique description of comfort in health care. She described 
comfort as “the immediate state of being strengthened by having the needs for relief, ease, and 
transcendence addressed in the four contexts of holistic human experience: physical, 
psychospiritual, sociocultural, and environmental” (Introduction section, para.1). Kolcaba’s
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comfort theory can be utilized to determine the existence and extent of unmet needs, designing 
interventions, and creating measurements of holistic comfort for documentation in practice and 
research (Kolcaba, as cited in Parker & Smith, 2010). This is particularly relevant to the DNP 
practice issue because the NCCN distress thermometer addresses the same domains: physical 
symptoms, spirituality, practical issues, family problems, and spiritual/religious concerns.
Although the concept of comfort is not unique to nursing, Kolcaba has developed a 
middle-range nursing theory that encourages nurses to define their unique contribution to patient 
care outside of the biomedical model. According to Kolcaba (2001), nurses are the ones 
primarily responsible for identifying and assessing the comfort needs of patients who experience 
a stressful life event. The comfort theory states the process of comforting a patient entails the 
intention to comfort, to be present, and to deliver comforting interventions based on the patients’ 
and loved ones’ unmet needs (Kolcaba, as cited in Parker and Smith, 2010).
The major concepts identified in Kolcaba’s comfort theory (2001) are: the identification 
of health care needs, comfort interventions, intervening variables, health-seeking behaviors, and 
institutional integrity. Kolcaba (1991) originally described three technical senses of comfort: 
state, relief, and renewal. These were later described as relief, ease, and transcendence (Kolcaba, 
2001). All of these concepts are related to the outcome of comfort and can be measured in terms 
of both patient comfort and family comfort.
Health care needs are defined as the need for comfort that cannot be met by the patients’ 
traditional support system (Kolcaba, as cited in Parker & Smith, 2010). These needs encompass 
physical, spiritual, sociocultural and environmental needs that are identified by patients and 
nurses. In the context of the DNP practice issue, health care needs may include practical
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problems (e.g., child care, housing), family problems, emotional problems, spiritual/religious 
concerns, and physical problems such as appearance, fatigue, nausea, and pain.
Literature Review
The goal of evidence-based practice is to promote optimal healthcare outcomes which are 
based on critically reviewed clinical evidence as well as the preferences and values of patients 
and families (Chism, 2013; Eaton & Tipton, 2009). Implementing evidence-based practice 
(EBP) at the bedside remains a formidable challenge for the majority of nurses. Successful 
implementation requires a multi-step process including: identifying the problem, formulating a 
question, finding the evidence, critically appraising and synthesizing the evidence; translating the 
evidence into practice; and evaluating the EBP change (Houser & Oman, 2011). Evidence-based 
oncology nursing practice is largely driven through the advancement of innovative scientific 
research on cancer treatment, supportive care, and promising patient outcomes. An 
overwhelming amount of data is available to help nurses manage cancer symptoms and side 
effects. The author has completed a systematic review of the literature in order to identify, 
select, assess, and summarize similar studies (see Appendix A). Several databases were searched 
including: CINAHL, MEDLINE, PsycINFO, and the Cochrane Library.
Psychosocial distress was the first key term searched within CINAHL and resulted in 
7,093 articles. The search was narrowed by adding the term ‘cancer’ and this resulted in 1,815 
articles. Finally, ‘distress thermometer’ was added to psychosocial distress and cancer resulting 
in 54 articles. A duplicate search was completed in MEDLINE and resulted in an initial 4, 171 
articles which were narrowed to 1,261 and finally 52 articles. The PsycINFO database revealed 
an initial 5,280 articles which was narrowed to 982 articles and finally 35 articles. The Cochrane
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Library search revealed an initial 26 articles and was narrowed to 11 articles. After the term 
‘distress thermometer’ was added to the search list, only one article was identified.
The National Comprehensive Cancer Network (NCCN) defines distress as a 
“multifactorial unpleasant emotional experience of a psychological (cognitive, behavioral, 
emotional), social and or/spiritual nature that may interfere with the ability to cope effectively 
with cancer, the physical symptoms, and its treatment” (NCCN, 2012, p. DIS-2). The term 
“distress” was chosen because it was felt to be less stigmatizing than “psychiatric”, 
“psychosocial” or “emotional” (NCCN, 2012). Distress symptoms can vary greatly from 
common feelings of vulnerability, sadness, and fear to problems including severe depression and 
anxiety that are disabling and require professional intervention (Fitch, 2011). Patient risk factors 
for distress include: a diagnosis of lung, brain, or pancreatic cancer, disability, and ongoing 
unmet needs (Carlson, Waller, & Mitchell, 2012; Keir, Calhoun-Eagan, Swartz, Saleh, & 
Friedman, 2008; Steinberg et al., 2009). Hurria et al. (2009) also found that poor physical 
function and age (>65) were predictors for elevated distress. Oncology patients residing in a 
rural area may also have an increased risk for distress (Smith, Limesand, & Alikhan, 2011). 
Screening for distress as an integral part of psychosocial care has become a major priority for 
numerous professional organizations as well as cancer treatment centers (Jacobsen & Wagner, 
2012).
Due to the potential negative impact on patient outcomes, all patients with cancer should 
be screened for evidence of psychological distress as part of routine care (Holland & Alici, 2010; 
Jacobsen, Holland, & Steensma, 2012). However, it has been noted that the process of 
identifying those needs and rendering the appropriate intervention and/or referral requires an 
assessment tool that can quickly yet effectively identify patients who are experiencing elevated
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levels of distress (Carlson et al., 2012). In an effort to meet this need, Roth et al. (1998) 
developed a “distress thermometer” that could be administered and interpreted rapidly by clinical 
staff. Patients who complete this assessment are asked to rate their distress using a scale with 
scores ranging from 0 (no distress) to 10 (extreme distress). This screening tool also has a 
problem checklist that highlights five potential areas of difficulty that may be linked to distress: 
practical, family, emotional, spiritual, and physical. Patients with a score of less than four are 
considered to have “mild” distress and can be managed by the primary oncology team. Patients 
with a score of four or greater are considered to have moderate to severe distress and should be 
referred to the appropriate professional (social worker, chaplain, psychologist, or other specialist) 
(NCCN, 2012). The National Comprehensive Cancer Network (2012) provides a structured 
algorithm that guides the clinician in making the appropriate referral based upon the patients’ 
level of distress. The goal of this assessment tool is not to identify all potential psychiatric 
disorders but rather to target and offer appropriate referrals for the most common sources of 
distress such as insurance/financial issues, fatigue, pain, nausea, and spouse/child problems 
(Holland & Alici, 2010).
Mitchell (2010) completed a review and diagnostic validity meta-analysis for cancer- 
related distress screening tools. A total of 45 potentially useful short and ultra-short tools tested 
and utilized within cancer and palliative care settings were identified. Only three of these tools 
had been tested against robustly defined distress (i.e., distress defined by semi-structured 
interview) in multiple samples (Mitchell, 2010). Only the Distress Thermometer (DT) and a 
single verbal question (1Q) were specifically validated against interview-defined distress in more 
than one independent sample. The DT was found to have a sensitivity of 78.5% and a specificity 
of 67.4% in multiple independent samples (Mitchell, 2010). Vodermaier, Linden, & Siu (2009)
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also completed a systematic review of tools used to screen patients for emotional distress. The 
authors concluded the DT had a moderate level of reliability (Cronbach’s alpha >0.60 and <0.80) 
and a moderate level of validity (average sensitivity and specificity <0.6 and <0.8). The Distress 
Thermometer Tool has been identified as an ultra-short, valid, and reliable screening tool that is 
inexpensive and easy to adopt in a clinical setting (Fulcher & Grosselin-Acomb, 2012; Hoffman, 
Zevon, D’Arrigo, & Cecchini, 2004; Jacobsen et al., 2005; Kendall, Glaze, Oakland, Hansen, & 
Parry, 2011; Lowery & Holland, 2011; Shimizu et al., 2010; Snowden et al., 2011; Vitek, 
Rosenzweig, & Stollings, 2007).
Despite the availability of valid and reliable oncology-specific screening tools, screening 
for distress has not been widely adopted in clinical practice. Jacobsen & Ransom (2007) 
reported only 53% of NCCN member institutions screen routinely for distress. A physician 
survey completed by the American Society of Clinical Oncology (ASCO) reported 65% of 
oncologists screen for distress; however, only 14% of these physicians reported utilizing a 
standardized screening instrument. Furthermore, only 35% of respondents indicated they were 
familiar with screening guidelines (Pirl, 2004). Mitchell, Lord, Slattery, Grainger, and Symonds 
(2012) reported only a minority of clinicians ask their oncology patients about emotional 
problems. Many clinicians preferred to rely on patients mentioning the problem during an office 
visit. The authors also reported that only 15% of clinicians use a screening tool and most of the 
clinicians preferred using their own clinical judgment (Mitchell et al., 2012).
Unfortunately limited data exists on the benefits of screening for emotional distress 
within the oncology population. Carlson, Groff, Maciejewski, and Bultz (2010) implemented an 
online distress screening program for new patients with breast and lung cancer. The primary 
objective of the study was to compare the efficacy of screening on subsequent distress.
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Secondary objectives included measures of anxiety and depression and to assess the 
impact of receiving referrals. Patients were randomly assigned to one of three groups: minimal 
screening, full screening, and full screening plus triage with a referral to resources. Patients 
randomized to the minimal screening group had the DT administered but no feedback was given 
to the patient. Patients in the full screening arm completed the DT, the DT problem checklist, 
fatigue and pain thermometers, and a test to measure anxiety and depression. Patients were 
printed a personalized feedback report and a summary report was placed in the electronic 
medical record. Patients randomized to the triage arm received all of the full screening plus they 
received a referral to speak to a member of the psychosocial team. The mean baseline score for 
all participants was high (4.33). Approximately 55% of all patients had a score of > 4  at the time 
of study enrollment. Patients randomized to the triage group showed significantly lower distress 
at three months compared with the minimal screening group (p=0.031). Patients over the distress 
cutoff score was significantly lower in the triage group (36%) compared to the full screening 
(46%) and minimal screening group (48.7%) (Carlson et al., 2010). The authors concluded 
intensive screening including feedback to patients and care providers followed by an appropriate 
referral helped to reduce future distress levels (Carlson et al., 2010).
Frost, Zevon, Gruber and Scrivani (2011) utilized the NCCN DT tool to measure the 
level of distress in head and neck cancer patients receiving chemotherapy in an ambulatory care 
clinic. A total of 763 patients participated in the pilot study. Approximately 19% of all patients 
had a score of four or higher on the 10-point DT scale; indicating a moderate to severe level of 
distress. The most frequently reported physical symptoms were fatigue (29%), pain (21%), sleep 
(20%), and eating difficulties (13%). Emotional problems included worry (24%), nervousness 
(19%), and both depression and fearfulness (11%). The authors concluded that early use of the
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DT helped to identify post-hospital placement, individual or family counseling needs, and 
financial issues. Furthermore, this pilot study demonstrated that the DT placed minimal burden 
on the nursing staff and was easy to implement in an outpatient clinic setting.
Psychological distress among women with newly diagnosed breast cancer has also been 
studied. Mertz et al. (2012) utilized the DT to determine the characteristics and extent of 
psychological distress among women at the time of their breast cancer diagnosis. A total of 343 
women completed the distress thermometer. When a score of three on the DT was used as the 
cut-off, 77% of women were categorized as experiencing distress. The results displayed a 
significant inverse association between distress and age; higher age was associated with lower 
distress with an odds ratio (OR) per year of 0.96, 95% CI [0.93, 0.98]. Worry (77%) and 
nervousness (71%) were the most frequently reported problem areas, followed by sleep 
disturbances (50%), fatigue (49%), and sadness (45%). The authors did not find a significant 
association between distress levels and the presence of a partner or family support.
Fulcher and Gosselin-Acomb (2007) completed a feasibility pilot study utilizing the 
distress thermometer in a radiation oncology center. A total of 57 patients completed the distress 
thermometer during a three month pilot study. The mean baseline distress thermometer score 
was 2.2. Eight patients had an increase in their distress score over the course of their treatment 
and 11 patients had a decrease in their score. All other patients had no change in their distress 
scores over time. The authors did note social worker, chaplain, and mental health referrals 
increased during this period. Furthermore, the authors noted that patient satisfaction scores were 
higher post-implementation (88.1% vs. 92.6%). Due to the sample size this particular study did 
not reach statistical significance. However, it can be argued that clinical significance was 
reached for several of these patients as well as the institution as a whole.
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O’Sullivan, Bowles, Jeon, Ercolano, and McCorkle (2011) studied the impact of 
advanced practice nursing (APN) interventions on the level of psychological distress during 
ovarian cancer treatment. The authors hypothesized women with suspected ovarian cancer who 
received a specialized nursing intervention program would have greater improvement in quality 
of life measures over time compared to women in an attention-control group. The use of the 
distress thermometer found that 24 of 32 women reported high levels of distress. Participants 
were divided into three subgroups: High distress/oncology APN plus referral to psychiatric 
APN, High distress/oncology APN only/refused psychiatric APN, and low distress/oncology 
APN only. There was no statistical difference in the mean number of total problems per contact 
in each of the groups. However, the findings did indicate that women with high levels of distress 
who received care from both an oncology APN and a psychiatric APN required fewer 
interventions per contact.
Hammonds (2012), a DNP student at the University of South Alabama, utilized the DT 
tool to identify elevated levels of distress in breast cancer patients receiving treatment at a 
university breast cancer clinic. A total of 104 patients participated in this quality improvement 
project. Patients with a DT score of > 4 were referred to a psychiatric mental health practitioner, 
social worker, chaplain, dietician, primary care provider, or oncologist. During the project 55% 
of participants were identified as experiencing a moderate or severe level of distress. The author 
concluded the DT is a brief and effective tool for identifying distress in oncology patients.
Swanson and Koch (2010) completed a retrospective chart review to collect information 
about whether or not the utilization of an oncology nurse navigator (ONN) would result in a 
decreased distress score for adult inpatients. The authors found that patients seen by the ONN 
tended to have lower distress scores on dismissal but this was not statistically significant
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(p=0.1046). However, there was a statistically significant effect on patients 65 years of age or 
younger (p=0.044) as well as patients from rural settings (p=.045). Skrutkowski et al. (2008) 
also examined the impact of an oncology nurse navigator on patient distress levels. Patients with 
lung or breast cancer were assigned to an intervention group with care by a ‘pivot nurse’ in 
oncology and usual care by clinic nurses or to a control group with usual care only. Participants 
in both groups were assessed for symptom distress, fatigue, quality of life, and healthcare 
resource usage. No significant difference was found in distress levels between the groups over 
time (p=0.675). However, the results did demonstrate a statistical significance in distress over 
time based upon the type of cancer. Patients with lung cancer had more distress than patients 
with breast cancer (p=.023).
In addition to the data regarding the benefits of distress screening, several authors have 
addressed the challenges of implementing a distress screening program in clinical practice. 
Barriers include lack of coordinated evidence-based psychosocial services, financial 
reimbursement, clinician training/expertise, screening time, resistance to change, and insufficient 
resources (Absolom et al., 2011; Carlson et al., 2012; Dudgeon et al., 2012; Fann et al., 2012; 
Fitch, 2011; Jacobsen, 2007; Jacobsen & Ransom, 2007; Madden, 2006; Mitchell, Vahabzadeh,
& Magruder, 2011; Pincus & Patel, 2009).
Oncology nurses can play a pivotal role in removing some of these barriers. Nurses must 
have the knowledge and skills to rapidly and accurately assess the psychosocial needs of their 
patients. Unfortunately many nurses have not received any formal education or training on how 
to perform a comprehensive holistic patient assessment. Spade and Mulhall (2010) developed a 
high-fidelity simulation exercise to teach undergraduate nursing students about the importance of 
holistic nursing assessments. The Psychosocial Vital Signs (PVS) curriculum was developed to
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help nursing students learn how to gather cognitive, affective, spiritual, and behavioral data 
about their patients (Spade & Mulhall, 2010). The simulation exercise allowed nursing students 
the opportunity to identify and assess a patient’s level of anxiety, coping, and sense of support. 
Nursing students were also taught how to devise, implement, and evaluate a patient-specific 
treatment plan. Although this model has not been tested or validated in a clinical setting, it does 
provide a conceptual framework for an innovative nursing curriculum designed to foster critical 
thinking and improved communication skills for nursing students.
Pasacreta, Kenefick, and McCorkle (2008) described the “ICAN: Distress Management 
for Oncology Nursing” online continuing education program designed to help oncology nurses 
integrate distress screening into their routine patient assessments. Developed by the American 
Psychosocial Oncology Society (APOS) and the Individual Cancer Assistance Network (ICAN), 
this webcast is available to any nurse interested in understanding how to identify, assess, and 
treat psychosocial distress in oncology patients. Content areas include: barriers to psychosocial 
care, appropriate use of resources, goals and benefits associated with psychosocial intervention, 
and psychosocial symptom management. This type of training program can help oncology 
nurses learn more about the essential components of psychosocial oncology and alleviate some 
of the traditional barriers to implementing a comprehensive distress management program.
Project Plan and Evaluation 
Market/Risk Analyses
A comprehensive needs assessment was completed prior to project implementation. This 
project was endorsed by the local Cancer Committee and is considered to be an integral part of 
oncology care as defined by the National Comprehensive Cancer Network (NCCN) as well as 
the American College of Surgeons (ACOS).
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While more than 577,190 Americans are expected to die of cancer in 2012, the survival 
rate for many cancers continues to improve (ACS, 2012). The five-year survival rate for all 
cancers diagnosed between 2001 and 2007 is 67%, a significant increase from 49% between 
1975 and 1977 (ACS, 2012). Unfortunately many advanced cancers are not curable and these 
patients will require extended periods of multi-modality treatment including numerous 
chemotherapy regimens with or without radiation therapy. For many patients, cancer will 
become a chronic disease which will require intensive surveillance and intermittent periods of 
treatment. As a result, some patients will endure prolonged periods of physical, spiritual, and 
emotional distress. These problems can adversely affect the quality of patients’ lives during their 
initial chemotherapy as well as many years into survivorship. Unfortunately, these problems can 
be magnified if a patient has any pre-existing psychological or social stressors that were present 
prior to the cancer diagnosis (IOM, 2008).
Strengths/Weaknesses/Opportunities/Threats
A comprehensive strengths, weaknesses, opportunities, and threats (SWOT) analysis for 
the DNP Capstone Project was completed (see Table 1). The project utilized an ultra-short, 
validated distress assessment tool as well as a comprehensive treatment algorithm. This allowed 
the advanced practice nurses (APN) the ability to rapidly identify a patient’s psychosocial needs, 
develop an individualized plan of care, and make the appropriate referral for treatment. The 
factors which might have impacted successful completion of the Capstone Project included the 
following constraints: clinician training/expertise, competing priorities, attrition rate, and space 
for privacy. Strategies to increase the likelihood of completion of the Capstone Project included 
comprehensive staff education, scheduled appointments, collaboration with an interdisciplinary 
team, and utilization of DNP Capstone mentors.
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Needs/Resources/Sustainability
The needs for the project included access to the patient population and their medical 
record, cooperation from staff and physicians, and institutional review board approval.
Resources included the NCCN Distress Management clinical practice guidelines, statistical 
analysis software, and interdisciplinary staff. Sustainability of this project is possible because 
the distress thermometer tool has already been incorporated into the electronic health record 
(EHR). Furthermore, the hospital cancer committee unanimously approved integrating this 
comprehensive psychosocial assessment program into the existing oncology service line 
program.
Feasibility/Risks/Unintended Consequences
Potential risks to this project include lack of acceptance and involvement by key 
stakeholders, competing priorities, and a reluctance to accept new clinical practice guidelines for 
distress management. This project may also reveal that patients are unsatisfied with their overall 
oncology care.
Stakeholders
Stakeholders for this project included: patients, physicians, nurses, insurers, ancillary 
staff, administrators, researchers, the American College of Surgeons (ACOS), the Joint 
Commission (JC), the Center for Medicare and Medicaid Services (CMS), and community 
agencies. The project team included Advanced Practice Registered Nurses (APRNs), infusion 
nurses, physicians, social workers, chaplains, financial counselors, patient navigator, 
administrators, and dieticians. Furthermore, additional support was provided by the DNP 
Capstone Mentor and Regis University DNP Faculty and Capstone Chair.
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Strengths:
Endorsed by Cancer Committee 
Respected, peer reviewed guidelines 
Comprehensive treatment algorithm
Proactive, holistic assessment
Ultra-short, validated tool
Interdisciplinary collaboration
American College of Surgeons (ACOS) Accreditation
Weaknesses:
Lack of formal referral process 
Poorly coordinated psychosocial services 
Clinician training/expertise 
Paper-based assessment 
Unfamiliarity of guidelines
Strategies to overcome:
Staff education
Develop a referral algorithm
Scan into EMR
Opportunities:
Decreased distress level 
Improved provider communication 
Improved patient satisfaction 
Improved patient trust and rapport
Decreased hospitalizations 
Increased quality of life 
Impetus for new programs 
Adoption of electronic tools
Threats:
Competing priorities 
Time constraints 
Space for privacy 
Attrition rate 
Reimbursement
Strategies to overcome:
Integrate into chemotherapy education appointment 
Utilize assistance of DNP Capstone Mentor 
Use of participant letter 
Scheduled appointments
Cost-Benefit Analysis
The costs and benefits of this project were determined prior to implementation. Direct 
costs included labor and supplies. The average assessment time per patient was 30 minutes. At 
an average cost of $55.00/hour x 84 assessments (21 participants x 4 assessments), the APRN 
salary expense was approximately $2,310.00. Copier paper and supplies were approximately 
$50.00. The Statistical Software Package for Social Sciences (SPSS) was $55.00. Indirect costs 
of this project were minimal due to the use of existing space, internet access, and support staff. 
The benefits of this DNP Capstone Project include: improved patient outcomes, enhanced 
communication between providers and patients, improved patient satisfaction, improved staff
retention, and enhanced institutional integrity. Furthermore, this project may identify current 
gaps in oncology care at that can be filled by new programs and/or services.
Mission/Vision/Objectives
The mission was to nurture and improve the quality of life for people with cancer. The 
goal of this project was the successful integration and application of the NCCN Distress 
Management guidelines for oncology patients. The core values of the Capstone Project included: 
comfort, compassion, respect, and collaboration. This DNP Capstone Project had a primary and 
secondary objective. The primary objective was to decrease the distress level in oncology 
patients receiving care in a rural ambulatory infusion center. The secondary objective was the 
formal institutional adoption of the NCCN clinical practice guidelines into routine cancer care.
Evaluation Plan
The logic model (see Appendix B) addresses several advanced practice nursing outcome 
measures including: care-related (cost of care, length of stay, readmission rates, office visits, 
quality of life); patient-related (compliance, symptom resolution, functional status); and 
performance-related (job satisfaction, performance ratings, collaboration, and quality of care). 
According to Kleinpell (2009), these groupings can be used to examine outcomes studies of APN 
care and help identify future research opportunities. The benchmark target is the incorporation of 
a standardized tool to identify, assess, and refer patients experiencing a heightened level of 
distress according to national practice guidelines. Patients appropriately screened and referred 
for distress will experience a decrease in their overall emotional distress level.
In addition to the numerous potential patient benefits, this project fostered an 
environment that supports interdisciplinary collaboration. The Institute of Medicine (2001) 
emphasized the need for providers and institutions to actively collaborate and participate in care
Cancer-Related Distress 16
coordination in order to improve patient safety and patient health outcomes. The doctorate- 
prepared advanced practice nurse should play a pivotal role in establishing these 
interprofessional teams (American Association of Colleges of Nursing, AACN, 2006). This 
Capstone Project was the impetus to fostering a professional, collegial relationship with multiple 
providers and stakeholders at Cheyenne Regional Medical Center.
Study Methodology/Instrumentation/Measurement
This evidence-based practice project consisted of implementing the National 
Comprehensive Cancer Network (NCCN) guidelines for distress management in oncology 
patients. All of the participants had a cancer diagnosis and were expected to receive 
chemotherapy for at least three months. Additional inclusion criteria included the ability to 
speak, read, and understand English and a baseline Eastern Cooperative Oncology Group 
(ECOG) score of < 2. There were 21 participants in the study. The project started on February
19, 2013 and was completed May 17, 2013 (see Appendix C).
At their initial infusion center appointment patients were provided information on the 
Comprehensive Oncology Patient Evaluation (COPE) project by the primary investigator or 
assistant investigator for this project. All new patients were asked to participate. Furthermore, 
all patients who had started chemotherapy within 30 days after Institutional Review Board (IRB) 
approval were also asked to participate. New chemotherapy patients were provided information 
about this project during their chemotherapy education session with an advanced practice 
registered nurse (APRN). Patients were provided a participant letter at the time of their 
education session (see Appendix D). Patients who already started their treatment (within 30 days 
after the project had been approved) were asked to participate during one of their subsequent 
infusions. All patients received extensive information about this project in a private, confidential
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office. Time was allotted for patients to ask questions and for the investigator to address any 
concerns.
The patients were interviewed by either the primary investigator or assistant investigator 
using the Ambulatory Infusion Center’s intake history and assessment forms. Both investigators 
for this project were advanced practice registered nurses (APRNs) employed at the Ambulatory 
Infusion Center. Patients were asked to complete the National Comprehensive Cancer Network 
(NCCN) Distress Thermometer checklist. The Distress Thermometer (DT) is a paper and pencil 
assessment took approximately five minutes to complete. Permission to utilize the DT had been 
granted by the National Comprehensive Cancer Network (NCCN) (see Appendix E). The 
Distress Thermometer instrument asked patients to rate their level of distress within the past 
week on a scale of 0-10 (0=no distress; 10=extreme distress) and complete the problem check list 
in each of the five areas linked to distress including practical, family, emotional, spiritual, and 
physical (see Appendix F). The National Comprehensive Cancer Network (NCCN) Distress 
Thermometer (DT) has a Cronbach’s alpha score of 0.86 (Moretz, 2002). A baseline DT 
assessment was completed by patients at the time they began their chemotherapy infusion or 
within 30 days of starting their initial infusion, and at least monthly during their chemotherapy 
infusion visits. Patients with a distress score of > 4 were individually assessed by an advanced 
practice registered nurse (APRN) and the appropriate referral was made based upon the 
guidelines in the NCCN treatment algorithm (see Appendix G).
Protection of Human Rights
To protect against the breach of confidential information, the project primary investigator 
assigned each chart a code number different from their medical record number. This code, not 
the patients name, appeared on the chart audit data collection instrument form (see Appendix H)
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that contains data collected from the patient's chart. The patient names, along with their codes, 
were stored in a locked file cabinet in the investigator’s office. The secondary investigator was a 
registered nurse with Collaborative Institutional Training Initiative (CITI) certification, was 
trained on the data collection processes for this project, and was supervised by the primary 
investigator (see Appendix I). The New England Insititutional Review Board as well as the 
Regis University Institutional Review Board approved this project (see Appendix J and K, 
respectively). Furthermore, this DNP Capstone Project was approved by the hospital Chief 
Compliance Officer (see Appendix L). Information was kept on a computer that is password 
restricted. The demographic information was filed separately from the questionnaires and will be 
destroyed five years after the close of the study.
Statistics
Data obtained from the chart audit was analyzed using the Statistical Product and Service 
Solutions (SPSS) software package. The patient's distress scores were analyzed to determine if 
there had been a decrease in their distress level. Descriptive statistics including frequencies, 
means, standard deviations, and ranges were completed on demographic data, ECOG scores, and 
distress scores. A repeated measures ANOVA was utilized to measure changes in distress scores 
over time. Reliability testing on the NCCN DT instrument was also completed.
Project Findings and Results 
Description of the Sample
A total of 21 ambulatory oncology patients participated in this project. See Table 2 for 
demographic characteristics. The mean age was 63 (range 44 to 84 years). Patients with all 
stages of cancer were included: stage I (5%), stage II (10%), stage III (29%), and stage IV 
(48%). The primary goal of treatment was palliation (71%). The most common diagnoses were:
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lymphoma (23%), breast cancer (14%), pancreatic cancer (14%), lung cancer (10%), and 
colorectal cancer (10%). The majority of participants (71%) had an ECOG score of one.
The majority of patients (57%) presented with clinical evidence of moderate to severe 
distress as evidenced by a distress score >4. The mean baseline score was 3.95 (SD, 3) and the 
median score was four with a range of scores from zero to nine. Physical problems were the 
most frequently identified source of distress during the initial assessment (19%). Participants 
were primarily referred to the oncology nurse practitioner for symptom management (95%).
At the time of the second assessment, 29% of patients reported a moderate to severe level 
of distress. The mean score for the second assessment was 2.52 (SD, 2). The median score was 
two with a range of scores from zero to seven. Practical problems were the most frequently 
identified source of distress during the second assessment (14%). Participants were referred to 
the nurse practitioner (17%) or financial counselor (10%).
Only 16 participants completed a third assessment. Of the patients who completed the 
third assessment, 38% of them had a distress score of > 4. Their mean score was 2.5 (SD, 3).
The median score was one with a range of scores from zero to nine. The majority of participants 
reported physical problems (10%). Participants were again primarily referred to the nurse 
practitioner for symptom management (20%).
The final assessment was completed by six participants. The other participants had 
completed treatment, died, or had a delay in their treatment beyond the three month timeframe 
allowed for this project. The mean score for the final assessment was 1.17 (SD, 2). Only one 
participant had an elevated distress score of > 4. Demographic data for the six participants who 
completed all four of the assessments were similar to the total population. The mean age was 67
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years (range 56-84). The goal of treatment was palliation (66%) and the most frequent diagnosis 
was pancreatic cancer (40%). All of these participants had an ECOG score of 0-1.
Table 2
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Demographic Characteristics
Patients
Characteristic No. %
Gender
Male 10 48
Female 11 52
Ethnicity
Caucasian 20 95
African American 1 5
Marital Status
Married 12 57
Single 1 5
Widowed 3 14
Divorced 5 24
Employment Status
Retired 12 57
Full Time 4 19
Unemployed 5 24
Insurance
Medicare 10 47
Medicaid 1 5
Private 8 38
Uninsured 2 10
Living Situation
Alone 4 19
Spouse 12 57
Extended Family 2 10
Other 3 14
Religion
Catholic 2 10
Presbyterian 1 5
Lutheran 1 5
Christian 3 14
None 7 33
Other 7 33
Comorbidities
Yes 17 80
No 4 20
Treatment Goal
Palliative 15 71
Curative 6 29
Objective One
A repeated measures ANOVA was completed to determine if there were significant 
differences in distress scores over time for the six participants. The Mauchly’s test of sphericity 
indicated the assumption of sphericity had not been violated (Chi-square=5.980, p=0.323).
There was a significant difference noted in distress scores over time (F=8.149, p=0.003). 
However, there was not a significant difference found in distress scores with a pairwise 
comparison (p=0.323). This can be explained in part due to the small sample size which impacts 
the Mauchly’s Test of Sphericity.
The Distress Thermometer (DT) was easy to administer and score. Reliability testing 
was completed on the Distress Thermometer (DT) with a Cronbach’s alpha of 0.677. This is 
slightly lower than the previously reported internal consistency of 0.86 (Mortez, 2002).
Patients who experienced a moderate to severe level of distress (DT score >4) were 
referred to the appropriate clinician based upon the NCCN distress management treatment 
algorithm. The majority of patients experienced elevated levels of distress due to physical 
problems as a result of their underlying cancer diagnosis or treatment. Physical problems were 
assessed and treated by the primary oncology team (advanced practice registered nurses and 
oncologists). Data analysis revealed that interdisciplinary referrals (mental health, social work, 
and chaplaincy) were limited during this project.
The high prevalence of psychosocial distress seen in this patient population is consistent 
with what has been reported in the literature. The Distress Thermometer (DT) facilitated the 
timely identification of concerns, thereby enhancing the opportunity for an early intervention. A 
high percentage of patients reported an elevated level of distress due to physical concerns at the
Cancer-Related Distress 22
time of their initial psychosocial evaluation. Aggressive symptom management and patient 
education, provided by the APRNs, was paramount to decreasing subsequent levels of distress.
Kolcaba’s comfort theory provided an excellent conceptual framework for this evidence- 
based project. The APRN benefited from developing meaningful relationships, addressing 
unmet psychosocial, physical, spiritual and environmental needs, and practicing according to her 
own values and patient care philosophy. Participants had their comfort needs met by engaged, 
professional, and empathetic nurses who were committed to reducing the level of distress in their 
patient population. Finally, the healthcare institution may reap the cultural and financial rewards 
for producing the best possible patient and family outcomes.
Objective Two
The findings of this evidence-based practice project were shared with the 
interdisciplinary cancer committee. Members of the interdisciplinary cancer committee 
reaffirmed their commitment to meeting the physical, emotional, spiritual, and practical needs of 
all cancer patients. The committee unanimously agreed to provide full administrative and 
clinical support to formally incorporate the NCCN distress management guidelines into routine 
oncology care. As a result of this project, a policy for psychosocial distress screening was 
written and approved by the cancer committee (see Appendix M). Furthermore, psychosocial 
distress screening has been fully integrated into routine oncology care for ambulatory infusion 
patients.
All oncology patients receiving care in the ambulatory infusion center are now screened 
for psychosocial distress at their initial visit and at least monthly during treatment. Assessments 
have been entirely integrated into the electronic health record (see Appendix N). Patients with 
a distress score of >4 are evaluated by the oncology advanced practice registered nurse (APRN)
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and referred to the appropriate clinician for treatment based upon the NCCN treatment algorithm. 
Oncology patients with clinical evidence of mild distress (score < 4) are managed by the primary 
oncology team.
Limitations, Recommendations, Implications for Change 
Limitations
The first limitation of this study was the sample size. It was estimated that 70 
participants would enroll in this project. However, due to the limited timeframe to complete this 
project, only 21 patients enrolled. The small sample size may have contributed to the lack 
statistical difference seen in individual distress scores over time. Furthermore, this project was 
conducted in a single institution and there was limited diversity seen within this patient 
population. Therefore, the results are not generalizable to other practice settings. 
Recommendations
Based upon these findings, all patients with cancer should be screened for distress at their 
initial visit and as clinically indicated. Patients with an elevated level of psychosocial distress 
should receive a comprehensive treatment plan to address their needs and be referred to the 
appropriate clinician for evidence-based treatment.
Implications for Change
Advanced practice registered nurses (APRNs) are in a unique position to make a 
difference in screening and managing elevated levels of distress in oncology patients. This 
evidence-based project demonstrated that APRNs have a positive impact on improving patient 
outcomes. Future research should be aimed at addressing additional nurse-sensitive outcomes 
including patient satisfaction, length of hospitalizations, compliance/adherence to treatment, and 
collaboration among care givers.
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Summary
Applying evidence to improve patient outcomes is the scientific underpinning for 
doctoral-prepared advanced practice nurses. The Doctorate of Nursing Practice (DNP) Capstone 
Project should “address a complex practice, process, or systems problem within the student’s 
field of expertise, propose an evidence-based intervention to address that problem for a 
significant population, and use doctoral-level leadership skills to implement and evaluate the 
efficacy of the intervention” (National Organization of Nurse Practitioner Faculties, 2007). This 
Capstone Project identified and assessed patients who were experiencing an elevated level of 
distress as measured by the NCCN Distress Thermometer. The NCCN clinical practice 
guidelines for distress management were utilized to ensure that patients received current, 
evidence-based treatment.
In addition to understanding the scientific underpinnings of advanced practice nursing, 
doctoral-prepared advanced practice nurses must also utilize nursing theories and values to guide 
their decisions and actions. This evidence-based practice project supports the need to develop 
meaningful relationships, address unmet psychosocial needs, and practice according to our 
philosophy of patient care.
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A p p en d ix  A
Systematic Review Evidence Table Format [adapted w ith perm ission from  Thom p son, C. (2011). Sam ple  evid en ce tab le  fo rm at fo r a system atic review . In J. 
H ouser & K. S. O m an (Eds.), E vid en ce-b a sed  pra ctice : An im plem entation  guide fo r  h ea lthca re  org an iza tio ns  (p. 155). Sudbury, MA: Jo n es and Bart ett.]
Database Research Author
and Design Population Methods/Study Primary Conclusions/
Author/Year Keywords and Level Studied/Sample Appraisal/ Outcome Implications
Article Title Funding of Study Size/Criteria/ Synthesis Measures of Key Strengths/
and Journal Source Evidence Aim/Purpose Power Methods and Results Findings Limitations Comments
Jacobsen, P. & CINAHL: Level VI Evaluate N/A Electronic survey 8 (53%) of Limited Limited to
Ransom, S. Psychologica progress in to 18 NCCN institutions progress on NCCN
(2007). l distress, implementing institutions; screened for implementing institutions;
Implementation cancer, distress responses distress. distress no
of NCCN distress distress management received from 15. Reasons for management community
management thermomete guidelines by 83% response not screening: guidelines. All hospitals.
guidelines by r. Funding: NCCN member rate considered institutions did Survey
member None institutions unnecessary; have mental methodology;
institutions. not enough health services need to
Journal of the resources to available. Only collect
National screen or refer 20% of quantitative
Comprehensive patients. member data from
Cancer Network, institutions patients.
5, 99-102. screened all 
patients for 
distress
Jacobsen, P., CINAHL, Level VI Determine the 380 patients at 5
Donovan, K., Keywords: optimal cutoff participating
Trask, P., screening, score on the institutions; all
Fleishman, S., psychologic distress given a packet of
Zaobra, J., Baker, distress, thermometer self-report
F., & Holland, J. cancer, (DT) for questionnaires:
(2005). distress identifying demographic/clini
Screening for thermomete clinically cal form, DT,
distress in r. No significant problem list,
ambulatory funding distress. HADS, and BSI-18.
cancer patients: source. Secondary Average age 56;
A multicenter objective: 51% male, 49%
evaluation of the Explore female. 85%
distress demographic White. Average
thermometer. or clinical DT score 3.41.
Cancer (7), 103, factors
1494-1502. differentiated 
patients who 
scored above 
or below this 
cut off score.
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DT 0-10 score; Using the Optimal
Problem list with HADS as the sensitivity and
34 commonly criterion, DT specificity was
experienced cutoff score of found utilizing
problems 4 yielded a a cutoff score
grouped into 5 sensitivity of of 4
categories. 77% and a
Clinically specificity of
significant 68%. Using
distress on HADS the BSI-18 as
>15. Clinically the criterion,
significant DT cutoff
distress on BSI-18: score of 4
Males_>10; yielded a
females_>13. sensitivity of 
70% and a 
specificity of 
70%. Chi- 
square 
analyses 
demonstrated 
only
significant 
variable was 
gender 
(women more 
likely to have 
score >4) and 
PS.
Large sample 
size; limited 
diversity with 
regard to 
race, 
ethnicity, 
education, 
and
socioeconomi 
c status. No 
conclusions 
about clinical 
benefit to 
screening for 
distress.
Mitchell, A. CINAHL Level 1 Diagnostic 45 potentially
(2010). Short Keywords: validity of useful short and
screening tools psychosocial tools to ultra-short tools
for cancer- distress, identify were identified.
related distress: cancer, distress in
A review and distress cancer and
diagnostic thermomete palliative
validity meta­ r. settings.
analysis. Journal
of the National
Comprehensive
Cancer Network,
8(A), 487-494.
Vitek, L., CINAHL: Level VII Reviewed None
Rosenzweig, M., Psychosocial nursing role
& Stollings, S. distress, and
(2007). Distress cancer, importance of
in patients with distress for screening
cancer: thermomete for distress
Definition, r. No
assessment, and funding
suggested source.
interventions.
Clinical Journal
of Oncology
Nursing 11(3),
413-418.
36
Systematic search 
of
Medline/PubMed, 
Embase, SCOPUS 
and Web of 
Knowledge.
Search limited to 
2007-2009. 
Focused on 
diagnostic validity 
studies of tools to 
identify distress in 
cancer and 
palliative care 
settings.
None
Only 3 tools Most tools are Searched only Good review
had diagnostic used to 2 years of of the multiple
accuracy or diagnose data; didn't screening tools
validity in depression and search that have been
cancer only a few have CINAHL or used as well as
settings with a been validated Cochrane the history of
primary focus in a cancer Library. visual analog
on distress: setting. Best scales (VAS)
HADS, Psychol evidence
ogical Distress supports the
Inventory NCCN Distress
(PDI), and the Thermometer
General (DT)
Health
Questionnaire
-12 (GHQ-12).
None Supports Review only DT better than
routine, HADS or Beck
proactive use Depression
of DT in Inventory.
oncology Discusses role
patients of oncology
nurses
Shimizu, K., CINAHL: Level VI Development 491 patients
Ishibashi, Y., Psychosocial of distress completed the
Umezawa, S., distress, screening distress and
Izumi, H., cancer, program in impact
Akizuki, N., distress ambulatory thermometer
Ogawa, A., thermomete care (DISPAC) (DIT) during the
Fujiwara, Y., r. Funding program in DISPAC period.
Ando, M., source: Japan 91.9% completed
Katsumata, N., Japanese the DIT, results
Tamura, K., Ministry of were positive in
Kouno, T., Health, 37% of patients.
Shimizu, C., Labor, and
Yonemori, K., Welfare.
Yunokawa, M., &
Uchitomi, Y.,
(2010).
Feasibility and
usefulness of the
distress
screening
program in
ambulatory care
in clinical
oncology
practice.
Psycho-
Oncology, 19,
718-725.
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Compare the 
proportion of 
patients referred 
to a psycho­
oncology service 
during the DISPAC 
period with the 
usual care period
DISPAC 5.3% of
program patients who
useful for complete the
facilitating the DIT were
care of treated by the
patients with psycho­
psychological oncology
distress. Only service
25% of compared to
patients the usual
accepted the number of
referral patients (0.3%).
P<0.001
Performed at What is the
a single DIT? Is it
center. different from
Comparison the NCCN DT?
group was not Validity?
a control Sensitivity?
group. May Specificity?
have been None of these
some bias were reported
since only
patients on
study were
referred to
psych team.
No
demographic
data. No
data on
patient
impact.
Pasacreta, J., CINAHL, Level VI Describes Reviewed and
Kenefick, A., & Keywords: online described
McCorkle, R. Psychosocial education participants and
(2008). distress, program for goals of program
Managing cancer, nurses to
distress in distress screen,
oncology thermomete recognize,
patients: r. No manage, refer,
Description of an funding and follow-
innovative source up/evaluate
online identified. distress in
educational cancer
program for patients
nurses. Cancer
Nursing ,31(6),
485-490.
Mitchell, A., CINAHL, Level III Data from Multiple statistics
Vahabzadeh, A., Keywords: primary care on screening
& Magruder, K. psychosocial physicians and failure and
(2011). distress, importance of treatment failure
Screening for cancer, partnering in primary care.
distress and distress with primary Identified under
depression in thermomete care & over detection,
cancer settings: r. No physicians to barriers to
Ten lessons from funding identify and identification,
40 years of source treat distress acceptability of
primary-care identified. in oncology screening,
research. patients importance of
Psycho-Oncology trust, frequency
(20), 572-584. of visits, clinician 
confidence/skills, 
and training
38
None None Must provide Good review Review the
educational of how to ICAN program
resources & overcome (joint venture
training for traditional between NCCN
oncology barriers to &APOS). Still
nurses in order distress available?
to screen and management. Future
identify distress direction:
in oncology does nurse
patients. education 
make a 
difference?
None None See population 
studied
Narrative Good review 
of historical 
data and 
barriers as well 
as failures 
within primary 
care to detect 
and treat 
distress
Spade, C. & CINAHL; Level VII Theoretical
Mulhall, M. Keywords: framework,
(2010). Teaching psychosocial assessing
psychosocial patients
vital signs across holistically,
the therapeutic
undergraduate relationship,
nursing measuring
curriculum. psychosocial
Clinical vital signs
Simulating in
Nursing, 6(4),
143-151.
Carlson, L., CINAHL; Level V Literature
Waller, A., keywords: review for
Mitchell, A. psychosocial psychometric
(2012). distress, distress
Screening for cancer, screening
distress and distress tools
unmet needs in thermomete
patients with r. No
cancer: Review funding
and sources
recommendatio identified.
ns. Journal of
Clinical
Oncology,
20(11), 1160-
1177.
None; not 
validated in 
clinical practice
None
39
None None Faculty Not utilized in Incorporates
implications clinical 
practice; not 
validated in 
any patient 
population.
nursing 
therapeutic 
relationship; 
has ideas 
regarding how 
to teach 
nurses how to 
assess for 
psychosocial 
stress
Authors utilized 30 articles Important to Excellent Discussed
Embase, Web of include all review of implementatio
Knowledge, and stakeholders distress tools n, needs to
PubMed from and frontline and needs screen unmet
inception to clinicians when assessments needs of
September 2011; screening for for specific underserved
studies were distress. populations populations
excluded if they as well as such as those
were not general with low
validated populations income, ethnic 
minorities
Fann, J., Ell, K. & CINAHL; Level V Systematic None
Sharpe, M. keywords: identification
(2012). psychosocial of need,
Integrating distress, integrated
psychosocial cancer, delivery;
care into cancer distress model for
services. Journal thermomete services to
of Clinical r. meet
Oncology, psychosocial
30(11), 1178- needs
1186.
Fulcher, C. & CINAHL. Level VI Pilot study in 57 Radiation
Gosselin-Acomb, Keywords: radiation oncology
T. (2007). psychosocial oncology to patients; total of
Distress distress, implement 157 assessments
assessment: cancer, NCCN DT
Practice change distress
through thermomete
guideline r. No
implementation. funding
Clinical Journal sources
of Oncology identified.
Nursing, 11(6),
817-821.
40
None None Need Great review How do we
evidenced- of challenges integrate
based and barriers. psychosocial
approach on rounds and
how to case
implement the management
psychosocial conferences?
guidelines! How do we 
partner with 
PCPs?
Delivered paper & Mean baseline DT was easy to Small, pilot Improved
pencil version of DT score 2.2. use and referral study. No Press Ganey
NCCN DT to 8 patients had process was statistical scores; patient
patients at initial an increase in simplified. significance. perception
visit and distress levels; Inconsistent was positive
treatment visits. 11 had a 
decrease in 
distress levels; 
all others 
remained the 
same.
use of DT by 
staff. Not a 
burden with 
nsg staff; built 
into normal 
clinical 
structure
Preyde, M., & CINAHL Level 1 Psychosocial Search terms:
Synnott, E. Keywords: interventions psychosocial,
(2009). psychosocial for adults care,
Psychosocial distress. No intervention,
intervention for funding service, support,
adults with source oncology,
cancer: A meta­ identified. effectiveness,
analysis. J ournal evaluation
of Evidence-
Based Social
Work, 6, 321-
347.
41
Articles from
MEDLINE,
CINAHL,
PsycINFO, Social 
Sciences Citation 
Index, Social 
Services 
Abstracts, 
PubMed 
databases from 
1999-2007. 27 
studies included.
Systematic 
review of 
psychosocial 
interventions 
for adults with 
cancer
Limited RCT 
studies.
Patient 
attrition 
problematic for 
many studies. 
Many studies 
have clinical 
significance.
Limited 
studies with 
quality 
ratings. 
Studies had 
small sample 
sizes. No 
statistically 
significant 
results of 
psychological 
or
psychosocial 
well-being or 
adjustment. 
Majority of 
trials were 
breast cancer. 
Studies had 
poor quality 
of reporting 
methods and 
results. 
Articles 
dated.
Carlson, L., Cochrane Level II Determine 588 patients with
Groff, S., Library. RCT best method breast cancer,
Maciejewski, 0., Keywords: of distress 549 patients with
& Bultz, B. psychosocial screening. lung cancer.
(2010). distress, 97.7% power to
Screening for cancer, detect difference
distress in lung distress of 1 point (Cl 95%,
and breast thermomete two-tailed test,
cancer r. Funded standard
outpatients: A by: Alberta deviation 3.0)
randomized Cancer
controlled trial. Foundation
Journal of & Canadian
Clinical Cancer
Oncology, Society
28(33), 4884-
4890.
MEDLINE: Level III Review of None
Fitch, M. (2011). psychosocial literature on
Screening for distress, screening for
distress: A role cancer. No distress and
for oncology funding role of
nursing. Current source oncology
Opinions in identified. nursing
Oncology, 23,
331-337.
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Patients Best predictor Routine High
randomized to of decreased screening is prevalence of
receive minimal anxiety and feasible in large distress in all
screening, full depression cancer center; groups at
screening, or full were patients may reduce baseline.
screening plus that received future distress
phone triage with full screening levels,
referral plus phone 
triage and 
referral
particularly 
when coupled 
with additional 
resources
None None Critical to 
identify 
distress; many 
tools available.
Incorporated 
role of nurses
Kendall, J., CINHAL: Level VI Data from Adult Medical and
Glaze, K., psychosocial 1,281 patients Radiation
Oakland, S., distress, seen in a Oncology
Hansen, J., & cancer, community patients.
Parry,C. (2011). distress cancer center. Administered DT
What do 1281 thermomete Reports
distress r. No intensity and
screeners tell us funding frequency of
about cancer sources. distress.
patients in a
community
cancer center?
Psycho-
Oncology, 20,
594-600.
Smith, J., CINHAL: Level VI 268 patients Partnership with
Limesand, D., & psychosocial completed the off-site local not-
Alikhan, A. distress; DT in for-profit cancer
(2011). cancer outpatient wellness center to
Prevalence of patients. No oncology provide services
psychosocial funding clinic.
distress in a rural sources.
community
oncology
practice and
impact of
interventions.
Journal of
Clinical
Oncology, 29,
(abstract 9114)
43
Utilized paper 32% had Distress Done at St.
version of DT. distress above screening can Joseph's in
Patients screened threshold be Denver
at initial visit and level. Worry accomplished
subsequent was most in a community
appts. Radiation common cancer center.
patients screened problem
weekly. followed by 
financial 
issues. 
Emotional 
concerns were 
endorsed by 
59% of sample
Outpatient Mean distress Prevalence of Abstract at
oncology clinic level 4.18. psychosocial 2011ASCO
46% scored distress higher Meeting
above the in rural
threshold (5 in population
this study). than
Only 10% urban/academi
accepted c outpatient
interventions clinics. Need to
at an off-site expand on-site
wellness cancer specific
center. support groups.
Lowery, A., & MEDLINE: Level V Reviewed Review of
Holland, J. psychosocial history of literature
(2011). distress; guidelines and
Screening cancer cancer. No routine
patients for funding screening as
distress: sources. standard of
Guidelines for care
routine
implementation.
Community
Oncology, 8(11),
502-505.
NCCN DT is a 
rapid screening 
tool; easy to 
implement. 
Incorporate as 
standard of 
care into 
practice.
Mitchell, A., MEDLINE:
Lord, K., Slattery, psychosocial
J., Grainger, L, & distress,
Symonds, P. cancer. No
(2012). How funding
feasible is source.
implementation
of distress
screening by
cancer clinicians
in routine clinical
care? Cancer,
March 2012.
Clinicians 
asked to 
record their 
feedback after 
implementatio 
n of a distress 
screening 
program
50 clinicians and 
379 patients in a 
large academic 
hospital in the UK
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Used the 
Emotional 
Thermometer 
(ET)
Clinicians 33% of Reviewed
believed clinicians clinician and
screening was 
useful in 43% of 
assessments. 
Assisted staff in 
changing their 
clinical opinion
considered 
screening not 
useful/practical 
. >50% 
believed
patient
perspectives
about perceived screening
distress levels. helped with
37.5% clinicians communication
fe lt that and recognition
screening was 
impractical for
of distress.
routine use. 3
variables
associated with
high staff
satisfaction:
prior training,
talking to
patient about
psychosocial
issues, and
improved
detection of
psychological
problems.
Absolom, K., Psychlnfo:
Holch, P., Pini, S., psychosocial
Hill, K., Liu, A., distress.
Sharpe, M., Funded by
Richardson, A., & NCRI
Velikova, G. Supportive
(2011). The and
detection and Palliative
management of Care
emotional Research
distress in Collaborativ
cancer patients: e Grant,
The views of University of
health-care Leeds
professionals.
Psycho-
Oncology, 20,
601-608.
Explore the Interviews with
views of 23 professionals
cancer (6 CNS, 8
professionals oncologists, 4
regarding their surgeons, 5 ward
current roles sisters) from
and hospitals in the
responsibilities UK.
in the
detection and
management
of emotional
distress, use of
screening
tools, and
access to
resources.
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Semi-structured 
interview 
schedule. 
Interview data 
analyzed using 
framework 
analysis to 
identify common 
themes.
Described how 
cancer 
professionals 
perceive their 
role and 
responsibilitie 
s in the 
detection and 
management 
of emotional 
distress. 
Attitudes 
towards the 
use of 
validated 
screening 
tools for 
detecting 
emotional 
distress.
Access to 
specialist 
supportive 
services.
Views of what 
currently 
limits the 
management 
of emotional 
distress.
All professionals 
acknowledged 
importance of 
detecting 
emotional distress 
in the ir patients. 
The CNSs were 
heavily relied upon 
to  assess patients, 
provide emotional 
support, and refer 
to  specialist 
services. 
Oncologists and 
surgeons did not 
consider emotional 
distress to  be a key 
part of the ir role. 
Main barrier was 
lack o f guidance on 
referral pathways 
to  help s taff decide 
when it was 
appropriate to  
refer, to  which 
service, and ho w to  
access the services.
Study sample 
small; drawn 
from one 
geographic 
location in 
the UK.
Excellent study 
to support 
utilization of 
NCCN
guidelines. All
staff needed
additional
training on
distress
assessment
and
management. 
Need for 
standardized 
screening 
tools.
Dudgeon, D., PsycINFO:
King, S., Howell, psychosocial
D., Green, E., distress,
Gibert, J., cancer. No
Hughes, E., funding
Lalonde, B., source
Angus, H., & identified.
Sawka, C. (2012).
Cancer care
Ontario's
experience with
implementation
of routine
physical and
psychological
symptom
distress
screening.
Psycho-
Oncology, 21,
357-364.
Ql initiative to Screening
implement increased from
routine 3.5% to 47%.
distress Palliative care
screening with clinics screened
ESAS for 70 to 90% of
cancer patients. 85% of
patients seen respondents felt
in 14 Regional it was
Cancer worthwhile. 44
Centers individuals 
participated in 14 
interviews and 7 
focus groups.
47
Used Edmonton 
Symptom 
Assessment 
System (ESAS) 
with a Calgary 
problem checklist 
as part of the 
recommended 
minimum 
standard for 
distress screening 
for patients in 
Canada.
Allow centers to 
examine the 
roles of 
different 
members of the 
health care 
team;
reorganize work 
flow  and 
responsibilities. 
Increase in 
educational 
activities for 
staff. Staff liked 
objective 
assessment. 
Algorithms and 
guides were 
developed to 
support further 
assessment and 
interventions. 
Demonstrated 
commitment to 
patient- 
centered care.
Routine 
screening is 
possible and 
creates a 
culture that is 
more patient- 
centered.
Canadian 
study; 
different 
distress tool
Currently 
evaluating 
feasibility of 
telephone 
survey.
Skrutkowski, M., CINAHL: Level II RCT; patients 3 outpatient
Saucier, A., psychosocial randomized ambulatory
Eades, M., distress, assigned to an oncology clinics in
Swidzinski, M., cancer. No intervention Quebec, Canada.
Ritchie, J., funding group with a 113 patients with
Marchionni, C., source pivot nurse lung cancer and
& Ladouceur, M. identified. and usual care 77 patients with
(2008). Impact by clinic breast cancer.
of a pivot nurse nurses or to a Participants
in oncology on control group completed
patients with with usual Symptoms
lung or breast care only. Distress Scale as
cancer: well as brief
Symptom fatigue inventory
distress, fatigue, and functional
quality of life, assessment of
and use of cancer therapy
healthcare scale. Variables:
resources. symptom distress,
Oncology fatigue level, QOL,
Nursing Forum, healthcare usage.
35(6), 948-954.
Madden, J. CINHAL: Level V Overview of N/A
(2006). The psychosocial incidence,
problem of distress, diagnosis, and
distress in cancer. No treatment of
patients with funding emotional
cancer: More source distress in
effective identified. patients with
assessment. cancer
Clinical Journal
of Oncology
Nursing, 10(5),
615-619.
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PNO reviewed 
diagnosis, 
expected side 
effects and 
available 
resources with 
patients. Also 
assessed patients' 
needs and coping 
skills.
Coordinated care 
across treatment 
modalities. Usual 
care consisted of 
symptom 
assessment and 
teaching but was 
not formally 
organized.
No significant 
difference in 
symptoms 
distress, 
fatigue, QOL, 
or healthcare 
usage. 
Statistically 
significant 
difference in 
distress over 
time based on 
cancer type; 
lung cancer 
group 
exhibited 
more distress 
than those in 
the breast 
cancer group 
p=0.023
Experienced 
nurses were 
able to offer as 
much care as 
PNO.
Ambulatory 
nurses were 
oncology 
certified; PNOs 
did not have 
any oncology 
background 
and were not 
certified.
Small sample 
size (target 
was 400).
Distress is 
common! 
Oncology 
nurses can 
become 
proficient at 
use of distress 
thermometer.
Limited
statistics
Pivot Nurse is
sim ilarto
nurse
navigator role 
in USA
Grassi, L. (2011). MEDLINE: Level VI Examine the Distress and
Educational psychosocial effect of an problems among
intervention in distress, educational newly diagnosed
cancer cancer, model on cancer patients
outpatient clinics distress distress who were
on routine thermomete screening in referred based
screening for r. No newly upon clinician
emotional funding diagnosed judgment and
distress: An source cancer after an
observational identified. patients education
study. Psycho- referred to a intervention on
Oncology, 20(6), Psycho- the DT.
669-674. Oncology 
Service (POS).
Frost, G., Zevon, MEDLINE: Level VI Social worker 763 patients
M., Gruber, M., distress pilot program screened; 19.6%
Scrivani, R. thermomete to implement had overall DT >4
(2011). Use of r. No DT in head & or higher. Most
distress funding neck cancer frequently
thermometer in source population identified physical
an outpatient identified. problems:
oncology setting. fatigue, sleep,
Heath & Social eating difficulties.
Work, 36(4), Emotional
293-297. problems: worry,
nervousness,
depression.
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Study 1: 
Physicians & 
nurses referred 
newly diagnosed 
patients by using 
their own 
judgment based 
on their
experience with 
fatigue. Study 2: 
Educational 
intervention was 
developed. 
Patients with DT 
score >4 were 
referred to POS.
Pilot program
Implementatio 
n of the DT 
determined a 
higher and 
more accurate 
referral of 
patients. 
Acceptance of 
DT by staff 
was low.
NCCN DT 
implementatio 
n for all head
& neck cancer 
patients
1/3 of patients 
referred based 
solely on 
clinician 
judgment did 
not show 
elevated levels 
of distress. Use 
of DT resulted 
in 79% increase 
in the accuracy 
of patients 
needing a 
referral.
Distress scores 
pre and post 
intervention 
were not 
measured.
Observational 
study; difficult 
to generalize
Conducted in 
single 
institution; 
may lim it 
generalizabilit
y
Hammonds, L MEDLINE: Level VI Pilot project 104 patients
(2012). distress done in an consented to
Implementing a thermomete academic participate. 55
distress r. No setting patients were
screening funding identified as
instrument in a source having elevated
university breast identified. level of distress
cancer clinic: A (DT >4). 11
quality patients were
improvement referred for
project. Clinical support.
Journal of
Oncology
Nursing, 16, (5),
491-494.
50
Pilot study DT increased Nurses are Small sample
nurse positioned to in one
identification identify distress institution.
of distress and among patients No
referrals for and make measurement
support. referrals for 
support. NCCN 
DT is an 
effective tool 
that can be 
used by nurses 
in busy 
settings.
of distress pre 
and post 
intervention.
Hurria, A., Li, D., MEDLINE: Level VI Determine the
Hansen, K., Patil, distress prevalence of
S., Gupta, R., thermomete distress in older
Nelson, C., r. Funding adults with
Lichtman, S., source: Paul cancer utilizing the DT.
Tew, W., Hamlin, Beeson Determine
P., Zuckerman, Career whether
E., Gardes, J., Developmen predictors of
Limaye, S., t  Award in distress could
Lachs, M., & Aging be identified
Kelly, E. (2009). Research & using a brief
Distress in older American geriatric
patients with Society of assessment that
captured
informationcancer. Journal Clinical
of Clinical Oncology about the
Oncology, Association individual's
27(26), 4346- of Specialty functional
4351. Professors
Junior
Developmen 
t Award in 
Geriatric 
Oncology.
status,
comorbid
medical
conditions,
psychological
state, social
support, and
nutritional
status.
Patients >65 in 
large academic 
setting. Patients 
completed the 
geriatric
assessment prior 
to the appt. 245 
patients 
completed the 
geriatric 
assessment. Of 
these, 214 
patients also 
completed the 
DT.
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Geriatric
Assessment & DT 
were utilized. All 
tumor types.
Mean DT score 
was 3; mean 
was 2. 41% of 
patients had a 
score of 4 or 
greater. 
Variables 
associated with 
higher levels of 
distress: 
needing 
assistance with 
ADLs (Pc.OOOl); 
Karnofsky <70 
(P=.001); having
3 or more 
comorbid 
conditions 
(P=.047), poor 
eyesight 
(P=.002), 
requiring 
services at 
home (P=0.52), 
and needing 
assistance to 
compete the 
geriatric 
assessment 
(P=.0Q3).
DT and geriatric 
assessment 
were used to 
explore 
relationship 
between 
distress and 
several 
variables that 
predict 
morbidity and 
mortality in 
older adults. 
Helped to 
pinpoint the 
unique causes 
of distress that 
face older 
adults with 
cancer.
Convenience 
sample; 
primarily 
females with 
breast cancer. 
Limits
generalizabilit 
y. Did not 
discuss how 
chemotherap 
y could make 
DT score 
higher or 
lower. Data 
was self- 
reported.
Mertz, B., MEDLINE: Level VI Determine
Bistrup, P., psychosocial prevalence of
Johansen, C., distress, distress and
Dalton, S., cancer. No investigate the
Deltour, 1., funding related
Kehlet, H., & source problems and
Kroman, N. identified. characteristics
(2012). of women
Psychological with breast
distress among cancer who
women with experienced
newly diagnosed psychological
breast cancer. distress at the
European time of
Journal of diagnosis.
Oncology
Nursing, 16(A),
439-443.
Jacobsen, P. & CINAHL: Level VII Review of
Wagner, L psychosocial standards,
(2012). Anew assessment, guidelines,
quality standard: cancer. No and quality
The integration funding measurement
of psychosocial sources
care into routine identified.
cancer care.
Journal of
Clinical
Oncology, 30,1-
6.
Women with 
newly diagnosed 
breast cancer 
prior to breast 
surgery. 426 
invited; 357 
responded. 343 
patients
completed the DT 
and DT problem 
list.
None
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Cross-sectional 77% of 12% accepted a Study done 1- Were these
data from a women had a referral to 2 days prior results
questionnaire. score >3; 43% psychological to surgery; expected pre-
scored >7. support, 54% may have operatively?
Mean distress asked for resulted in
score 5.4. possible future increased
Most frequent referral, 30% number of
problems: refused women
worry & referral. experiencing
nervousness. worry about
Younger the surgery.
women (<50) Many physical
had higher symptoms
distress scores generally
than older related to
women (>50). chemotherap
No significant y (fatigue,
association mouth sores)
between were
distress and reported prior
social support. to surgery.
None None Overview of 
accomplishmen 
ts in standards 
of care, clinical 
practice 
guidelines and 
development of 
measurable 
indicators of 
quality
No review of
patient
outcomes
Snowden, A., Medline: Level 1 Meta-analysis Searched
White, C., Psychosocial review to Medline, CINAHL,
Christie, Z., distress, ascertain use PsycINFO,
Murray, E., distress of DT in Embase, ASSIA,
McGowan, C., & thermomete clinical British Nursing
Scott, R. (2011). r. No practice Index, AMED,
The clinical funding CCTR and HMIC.
utility of the sources
distress identified.
thermometer: A
review. British
Journal of
Nursing, 20(4),
220-227.
Psychlnfo: Level IV Prevalence 98 consecutive
psychosocial and associated patients with
distress, symptoms of newly diagnosed
cancer. distress in NSCLC or SCLC
Funded by newly asked to
Steinberg, T., an diagnosed completed the DT
Roseman, M., unrestricted lung cancer and ESAS as their
Kasymjanova, G., grant from patients first visit post­
Dobson, S., Sanofi- diagnosis and
Lajeunesse, L, Aventis. prior to any
Dajczman, E., treatment. Mean
Kreisman, H., age 63, M/F ratio
MacDonald, N., 54:44. 81'% of
Agulnik, J., patients had PS of
Cohen, V., 0-1.
Rosberger, Z.,
Chasen, M., &
Small, D. (2009).
Prevalence of
emotional
distress in newly
diagnosed lung
cancer patients.
Support Care
Cancer, 17,
1493-1497.
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Identified 40 
stories that 
examined the 
function of the DT 
alone, together 
with the problem 
list, and other 
validated 
measures.
DT score of 4 
is appropriate 
for distress 
screening; 
additional 
studies in 
oncology 
practice 
needed.
Limited studies 
available to 
review
ESAS is a 
numerical rating 
scale that 
assesses 9 
physical and 
psychosocial 
symptoms 
common in 
cancer patients. 
DT cut o ff score 
was 4.
Level of 
distress not 
associated 
with age, sex, 
weight loss, or 
performance 
status. 51% of 
patients were 
identified as 
distressed by 
the DT at the 
time of 
diagnosis. 
Mean level of 
distress 
assessed by 
the DT was 
3.64.
Depression
and
nervousness
were
significant 
predictors of 
elevated 
distress score.
Prevalence of 
distress in lung 
cancer patients 
is high. Single­
item DT is 
extremely 
useful
instrument to 
rapidly identify 
elevated levels 
of distress.
Excellent 
review of 
literature; 
correlates 
closely to the 
Capstone 
project. 
Limited to 
lung cancer 
patients. Did 
not measure 
the impact of 
any
interventions.
PsycINFO: Level IV Evaluated the 75 patients
Psychosocial extent and diagnosed with a
Keir, S., Calhoun- distress, sources of primary brain
Eagan, R., cancer, distress in cancer. Inclusion
Swartz, J., Saleh, distress patients with criteria: at least
0., & Friedman, thermomete brain cancer age 18, ability to
H. (2008). r. No speak, read, and
Screening for funding write English,
distress in source Karnofsky score
patients with identified. >70
brain cancer
using the NCCN's
rapid screening
measure.
Psycho-
Oncology, 17,
621-625.
Holland, J., & CINAHL: Level VII Overview of None
Alici, Y. (2010). Psychosocial assessment
Management of distress, and
distress in cancer. No management
cancer patients. funding of distress as
Journal of sources well as
Supportive identified. common
Oncology,8(1), 4- psychiatric
12. disorders 
experienced 
by oncology 
patients.
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Participants asked 52% of Interventions Did not study
to complete patients had a should be any
written DT DT score > 4. designed to 
address worry, 
sadness, and 
depression 
seen in brain 
cancer 
patients.
interventions
None None
Important to 
screen and 
identify
patients at risk.
Need further
research to
improve
assessment and
treatment of
distress;
especially
among
underserved
population.
Nice review of
psychiatric
disorders.
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Jacobsen, P., 
Holland, J., 
Steensma, D. 
(2012). Caring 
for the whole 
patient: The 
science of 
psychosocial 
care. Journal of 
Clinical 
Oncology, 
30(12), 1-3.
CINAHL:
psychosocial
distress,
cancer. No
funding
source
identified.
Level VII Summary of 
recent science; 
importance of 
screening and 
referral per 
the NCCN 
Guidelines.
None None None Promotes
greater
knowledge and 
understanding 
of psychosocial 
care
Introduction 
for special 
oncology 
issue
dedicated 
solely to 
distress 
screening
Jacobsen, P. 
(2007). 
Screening for 
psychological 
distress in 
cancer patients: 
Challenges and 
opportunities. 
Journal of 
Clinical 
Oncology, 
25(29), 4526­
4527.
CINAHL:
Psychosocial
distress,
cancer. No
funding
source
identified.
Level VII Need for 
adopting the 
NCCN 
guidelines
None None None Recognizes 
need for RCTs
None
Pincus, H. & 
Patel, S. (2009). 
Barriers to the 
delivery of 
psychosocial 
care for cancer 
patients: 
Bridging mind 
and body. 
Journal of 
Clinical
Oncology, 27(5), 
661-662.
CINAHL:
Psychosocial
distress,
cancer. No
funding
source
identified.
Level VII Barriers to 
implementing 
the NCCN 
Guidelines.
None None None Emphasizes 
need to identify 
patients, link 
them to 
appropriate 
resources, 
coordinate 
care, and 
follow up on 
care delivery
Kadan-Lottick, Medline: Level VI Determine the 251 patients with
N„ psychosocial prevalence of advanced cancer.
Vanderwerker, distress, diagnosable Eligible patients:
L., Block, S., cancer. psychiatric distant mets,
Zhang, B., & Funded by illness and primary therapy
Prigerson, H. the National describe the failure, nonpaid
(2005). Institute of mental health caregiver, age
Psychiatric Mental services >20, English or
disorders and Health. received and Spanish speaking,
mental health predictors of adequate
service use in service cognitive ability.
patients with utilization in
advanced patients with
cancer. Cancer, advanced
104, 2872-2881. cancer.
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Trained 
interviewers 
administered the 
DSM-IV modules 
for MDD, GAD, 
panic disorder, 
PTSD, and 
questionnaire 
regarding mental 
health service 
utilization.
12% patients 
met criteria for 
major 
psychiatric 
condition; 28% 
had access a 
mental health 
intervention for 
psych diagnosis 
since the cancer 
diagnosis. 17% 
had talked to a 
mental health 
professional; 
90% willing to 
receive 
treatm ent fo r 
emotional 
problems. 
Mental health 
services were 
not accessed by 
55% of patients 
w ith major 
psychiatric 
conditions.
Advanced cancer 
patients
experience major 
psych disorders 
at a prevalence 
similar to general 
population but 
affected 
individuals have 
a low rate of 
utilizing mental 
health services. 
Oncology 
providers should 
discuss mental 
health concerns 
w ith their 
patients.
Only 63% 
participation 
rate; potential 
for bias.
Mitchell, A., Medline: Level 1 Quantitative Searched
Chan, M., Bhatti, Psychosocial summary of Medline,
H., Halton, M., distress, the prevalence PsycINFO,
Grassi, L., cancer. No of depression, Embase, and Web
Johansen, C., & funding anxiety, and of Knowledge
Meader, N. source adjustment sites for studies
(2011). identified. disorders. that examined
Prevalence of depression,
depression, anxiety, and
anxiety, and adjustment
adjustment disorders in
disorder in adults with
oncological, cancer. Studies
haematological, restricted to
and palliative those using psych
care settings: A interviews.
meta-analysis of
94 interview-
based studies.
Lancet Oncology,
1 2 ,160-174.
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24 studies with 16.5 % rate of
4007 patients depression,
were identified. 15.4% rate of
Included 7 adjustment
countries. disorder, 9.8%
rate of
anxiety. No
consistent
correlates of
depression; no
effect of age,
sex, clinical
setting, cancer
type or
duration.
Depression and Not a
anxiety is less longitudinal
common in study. Did
cancer patients not examine
than previously stage of
reported. disease or
duration of
treatment.
Only used
interview-
based studies
Swanson, J. & Medline: Level VI To determine Retrospective
Koch, L. (2010). Psychosocial if an ONN role chart review,
The role of the distress, as an convenience
oncology nurse cancer. intervention sample o f 55
navigator in Funded by decreases the inpatients.
distress the National distress of
management of Cancer adult
adult inpatients Institute. inpatients with
with cancer: A cancer.
retrospective
study. Oncology
Nursing Forum,
37(1), 69-76.
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Nurses asked 
patients with 
cancer to rate 
their distress daily 
during their stays. 
Correlation 
studies and two- 
tailed t tests used 
to examine the 
relationship 
between the 
change in distress 
and the ONN 
intervention.
Patients seen 
by ONN had 
lower distress 
scores on 
dismissal 
(p=. 1046). 
Statistically 
significant 
effect for 
patients <65 
years (p=.044) 
and for 
patients who 
live in a rural 
setting 
(p=.045).
ONN can lower
cancer-related
distress scores,
increase
patient
satisfaction?
Increase QOL?
Retrospective 
chart audit; 
involved 
inpatients 
only.
Vodermaier, A., CINAHL: Level 1 Examined the Systematic search
Linden, W., & Psychosocial psychometric of Medline and
Siu, C. (2009). distress, properties of PsycINFO
Screening for cancer, existing tools databases.
emotional distress used to screen Keywords:
distress in thermomete patients for depression,
cancer patients: r. Funded emotional anxiety,
A systematic by the distress. screening,
review of Canadian validation, and
assessment Institutes for scale. Validation
instruments. Health criteria: # of
Journal of the Research. validation studies,
National Cancer # of participants,
Institute, generalizability,
101(21), 1464- reliability, quality
1488. of criterion 
measure, 
sensitivity, and 
specificity.
Pirl, W. (2004). CINAHL: Level 1 Literature Systematic search
Evidence report psychosocial review on PubMed,
on the distress, depression in PsycINFO,
occurrence, cancer. No people with CINAHL, and
assessment, and funding cancer: Biosis. Terms:
treatment of sources occurrence, neoplasms,
depression in identified. assessment & depression,
cancer patients. treatment. depressive
Journal of the disorder,
National Cancer antidepressant
Institute, 32-39. agents
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Yielded 106 
validation studies 
that described 33 
screening 
measures
350 studies 
identified; limited 
by English 
language 
published 
between 1966 
and 2001.
Ultra short Several generic Reviewed a
measures did and newly large number
best in develop of tools;
palliative care specific unable to
settings; best instruments judge the
short met the high- predictive
measures quality criteria validity of
were ESDS & for use in tools. Need
HADS, best emotional more
long measures distress information
GHQ. 15 screening of on how
studies cancer screening
utilized the DT patients. Best affects long­
for a total of to use the term
4,088 shortest tool outcomes and
participants. + that is easiest QOL
Generalizabilit for clinician to
y; moderate interpret.
reliability,
moderate
criterion
measures,
moderate
validity, Fair
judgment.
Majority of DSM Manual No RCTs or
studies are Criteria for alternative
cross-sectional MDD is the med studies.
prevalence standard Need
studies. assessment longitudinal
Prevalence tool studies to
rates vary estimate the
widely; data incidence of
suggests depression
approx. 10- before cancer
25% of cancer dx
patients suffer
from MDD.
Roth, A., CINAHL: Level VI Use rapid Median age 71,
Kornblith, A., distress measure tool diagnosed a
Batel-Cooper, L., thermomete to identify median of 4 yrs.
Peabody, E., r. patients with DT cut o ff score 5;
Scher, H., & Supported distress; 28.6% score at or
Holland, J. by grants compared above this score.
(1998). Rapid from HADS with DT
screening for PepsiCo
psychologic Foundation
distress in men and the T.J.
with prostate Martell
cancer: A pilot Foundation.
study. Cancer,
82(10), 1904-
1908.
60
121 consecutive 
men with 
prostate cancer 
asked to 
complete the 
HADS and the DT
Patients with 
score >5 on DT 
or >15 on 
HADS were 
referred to 
psych MD for 
assessment; 
31% of 
patients were 
evaluated by 
MD. Good 
correlation 
between 
elevated DT 
scores and 
presence of 
distress as 
measured by 
DSM criteria
Rapid screening 
approach was 
acceptable to 
patients and 
clinicians
No data on 
pre and post 
intervention
O'Sullivan, C., CINAHL:
Bowles, K., Jeon, psychosocial
S., Ercolano, E., distress,
McCorkle, R. cancer,
(2011). distress
Psychological thermomete
distress during r. Funded
ovarian cancer by a grant
treatment: through the
Improving NIH.
quality by
examining
patient problems
and advanced
practice nursing
interventions.
Nursing
Research and
Practice, 1-14.
Single blind 145 subjects
prospective randomized
RCT, designed following surgery
to test the All screened for
hypothesis DT at baseline
that women and prior to
with hospital
suspected discharge. DT
ovarian cancer cut-off score was
who received 4.
a specialized
nursing
intervention
program
would have
greater
improvement
in QOL
measures over
time than
women in an
attention-
control group.
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Secondary 
analysis of 
research records 
from a 6 month 
RCT included 32 
women with 
primary ovarian 
cancer. All 18 
received APN 
visits over 6 
months. 
Demographic, 
clinical factors, 
patient problems 
and APN 
interventions 
obtained through 
content analysis 
and categorized 
via the Omaha 
system.
Clinically 
significant psych 
conditions were 
identified in 
44% of 
participants 
who had 
elevated DT 
scores; they 
agreed to psych 
referral. High 
distress subjects 
who refused 
mental health 
intervention 
had more 
income and 
housing 
problems than 
the other 
subjects, 
received the 
fewest
interventions at 
baseline and 
received 
progressively 
more
interventions 
throughout the 
study.
Highly 
distressed 
women not 
psychologically 
ready to work 
through 
emotional 
consequences 
of cancer at 
treatment 
onset may 
obtain support 
from APNs to 
manage cancer 
problems as 
they arise.
Retrospective 
chart audit, 
ovarian 
cancer 
population 
only. Sample 
lacked 
diversity.
Appendix B: Logic Model
Project:
Im plem entation o f NCCN Distress Therm om eter (DT)
Problem Identification:
• D ifficu lty making trea tm en t decisions
• Poor compliance to  trea tm ent
• Extra visits to  medical providers
•  Poor satisfaction w ith  ca re
• Poor qua lity  o f life
-O ncology Patients 
-NCCN D TTo ol 
-NCCN Algorithm  
Infusion Staff 
-Chaplains 
-Dieticians 
-Psychotherapists  
-Social W orkers (SW ) 
-Physicians 
-Com puter/ Database
-Assessm ent tim e  
-Staff education 
-Space for privacy  
-Consult schedule  
-Staff com m unication  
-Tim efram e 
-Patient privacy  
-Fam ily concerns 
-Cultural concerns
-Adm inister NCCN DT 
assessm ent 
-M edications 
-Lab Testing  
-Case Mgr. Referrals 
-Hospice Referrals 
-Dietary Consults 
-SW Consults  
-Psych Referrals 
-Transportation requests 
-Pain M gmt. Referrals 
-PT/O T Referrals 
-Lym phedem a Referrals 
-Support Groups 
-M eals on W heels
-70 Participants 
-Baseline DT score 
-Consultations  
-M onthly Assessm ents 
-Changes in DT scores 
-Fam ily/caregiver 
support
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Appendix C: Project Timeline
1/14/2013
2/19 /2013  5 /19 /2013
Recruitm ent begins Recruitm ent Ends
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February 2013 
Dear Participant:
My name is Denise Sartz. I am a student at Regis University in the Doctorate of Nursing 
Program under the supervision of Dr. Diane Ernst. You are invited to participate in an evidence- 
based project entitled: Screening for Distress in Ambulatory Oncology Patients: The COPE 
Project. You have been asked to be a part of this project because you have been diagnosed with 
cancer and you are receiving treatment at Cheyenne Regional Medical Center. The purpose of 
this project is to identify new programs and services that will improve care for oncology patients 
receiving their treatment at Cheyenne Regional Medical Center. This project has been approved 
by Regis University’s Institutional Review Board as well as Cheyenne Regional Medical Center.
If you agree to participate in this project, I will ask you to complete a written checklist called a 
“distress thermometer” at least monthly during one of your visits to the ambulatory infusion 
center at Cheyenne Regional Medical Center. The checklist will take approximately 5 minutes 
to complete. You will also meet with an advanced practice nurse at each visit to review the 
results of the checklist. If you are experiencing distress during any part of your treatment, you 
will be offered additional care and support which may include: a chaplain, dietician, financial 
counselor, mental health professional, or other specialist. Your participation will last 
approximately 3 months. If you need help with distress after the project has been completed you 
will continue to receive treatment and support.
Your participation in this project is confidential. None of the information will identify you by 
name. All records will be stored in a locked cabinet which can be only be accessed by me or a 
co-investigator. The results of this project may be presented at meetings or in publications; 
however, your identity will never be disclosed in those presentations or publications.
There are no direct costs to you for participating in this project. You or your insurance company 
will be charged for any medical care and/or hospitalizations related to your cancer treatment.
You will not be paid for taking part in this project.
Please take your time making a decision and feel free to discuss it with your family and friends. 
If you have additional questions or concerns please contact me at: 307-633-6875 or 307-274­
7827. You can also reach me via email at: denise.sartz@crmcwy.org. You can also contact my 
project advisor, Dr. Diane Ernst, at 303-964-5768 any time during this project.
Sincerely,
Appendix D
Denise A. Sartz, MS, AOCNP, FNP-C
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Appendix E
December 12, 2012 
Denise Sartz
Cheyenne Regional Med Ctr 
214 E. 23rd St 
Cheyenne, Wyoming 82001
On behalf of the National Comprehensive Cancer Network® (NCCN®), I am writing to grant you 
permission to reproduce the Distress Thermometer Screening Tool Figure (DIS-A) from the NCCN 
Clinical Practice Guidelines in Oncology (NCCN Guidelines®) fo r Distress Management V.2.2013 as
described in your original request for use with your patients. Permission is granted solely for the 
purposes described herein, which you represent and warrant to be for non-promotional educational use 
only. The following qualifications also apply to the permission granted by this letter:
1. You agree to include a citation giving full credit to the NCCN Guidelines® as follows:
Reproduced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN 
Guidelines®) fo r Distress Management (V.2.2013). © 2012 National Comprehensive Cancer Network, 
Inc. Available at: NCCN.org. Accessed [Month and Day, Year]. To view the most recent and complete 
version of the NCCN Guidelines®, go on-line to NCCN.org.
2. Permission is granted solely for the purposes described within your original request and expires after 
one year. An extension on your permission request may be requested at that time.
3. You agree that you will not translate, change, adapt, delete, extract portions, or modify the content of 
the NCCN Guidelines® fo r Distress Management, unless explicit permission is provided above.
4. Permission is for reproduction of the NCCN Guidelines in print media only. No Electronic Rights 
(including CD-ROM and Internet) are granted. Reproduction of the NCCN Guidelines into any other 
medium, including but not limited to electronic media, is explicitly prohibited. You further agree that any 
reproduction of the NCCN Guidelines will include NCCN’s URL address www.nccn.org, to link to the most 
updated version of the NCCN Guidelines fo r Distress Management.
5. Permission is granted for reproduction in the English language only.
6. You acknowledge that the NCCN is sole owner of the NCCN Guidelines, and any derivative works 
created from the guidelines. You further acknowledge that National Comprehensive Cancer Network®, 
NCCN®, NCCN Guidelines®, NCCN Compendium®, NCCN Templates®, GUS™, NCCN Flash Updates™, 
NCCN Trends™ Surveys & Data, and NCCN Oncology Insights Reports™ are trademarks owned by the 
National Comprehensive Cancer Network, Inc. You agree that you shall not use the Marks in any manner 
or for any purpose other than to acknowledge ownership of the NCCN Guidelines as described in this 
letter. Your use of the Marks and/or Guidelines for the purposes described herein in no way constitutes 
an endorsement of your works or opinions by the NCCN. You acknowledge that use of the Marks and 
reprinting of the Guidelines pursuant to the permission granted hereunder shall not create in your favor 
any right, title, or interest in or to the Marks and/or the Guidelines. The permission granted hereunder is 
for a one-time use of the Marks and/or Guidelines. You agree that each use of the Marks and/or the 
Guidelines by you, beyond or in addition to that described herein, shall require written approval by the 
NCCN.
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7. Your use of the Marks and/or Guidelines as described herein shall signify your acceptance of the terms 
and conditions of this letter. The NCCN reserves the right to at any time revoke the permission granted 
hereunder if, in its discretion, the NCCN determines that you have violated or are in violation of the terms 
of this letter of permission.
Thank you for your interest in the work of the NCCN. 
Sincerely,
John A nao
John T. Arnao
Business Development Coordinator 
National Comprehensive Cancer Network
Additional Information on the NCCN Guidelines:
The NCCN Guidelines® - the recognized standard for clinical policy in oncology - are the most comprehensive and most frequently 
updated clinical practice guidelines available in any area of medicine. Covering 97 percent of all patients with cancer and updated 
on a continual basis, the NCCN Guidelines are developed through an explicit review of the evidence integrated with expert medical 
judgment and recommendations by multidisciplinary panels from NCCN Member Institutions. There are 44 individual panels, 
comprising nearly 900 clinicians and oncology researchers from the 21 NCCN Member Institutions and their affiliates. Specific 
treatment recommendations are implemented through performance measurement. NCCN Guidelines Panels address cancer 
detection, prevention and risk reduction, workup and diagnosis, treatment, and supportive care.
NCCN Guidelines have become the most widely used guidelines in oncology practice and have been requested by cancer care 
professionals in more than 115 countries. There has also been substantial international interest in translating the NCCN Guidelines 
into a variety of languages. Select NCCN Guidelines have been translated into Chinese, German, Italian, Japanese, Korean, Polish, 
Portuguese, Russian, Spanish, and Turkish.
© National Comprehensive Cancer Network, Inc 2012, All Rights Reserved. National Comprehensive Cancer Network®, NCCN®, NCCN Guidelines®, 
NCCN Compendium®, NCCN Templates®, GUS™, NCCN Flash Updates™, NCCN Trends™ Surveys & Data, and NCCN Oncology Insights Reports™ 
are trademarks owned by the National Comprehensive Cancer Network, Inc.
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Updates in vers ion  2.2013 o f the  NCCN G uidelines fo r  D istress Management from  Version 1.2013 include:
•  The “ Recom m ended Readings fo r  Im plem enta tion o f P rogram s tha t Integrate Psychosocia l Care in to  the  Routine Care o f Patients w ith  
Cancer”  reference lis t was m oved from  the D iscussion  to  the  a lgorithm . (DI5-281
•  The D iscussion tex t was updated to  correspond to  the changes in the  a lgorithm . (MS-1)
Updates in vers ion  1.2013 o f the  NCCN G uidelines fo r  D istress Management from  Version 3.2012 include:
DIS-5
•  Under In terventions: “ S p iritua l su p p o rt”  was added.
DIS-A Screening Tools fo r  M easuring D istress
•  “ Substance abuse” was added to  the  lis t o f Physical Problem s.
DIS-B (Psychosocia l D istress Patient C haracte ris tics)
•  Periods o f Increased V u lnerab ility : The second bu lle t changed to  “ During d iag nos tic  w o rku p ” .
DIS-10 (Mood D isorder)
•  Danger to  s e lf o r  o thers: The th ird  bu lle t changed to  “ C onsider rem oving sha rp  dangerous ob jec ts ” .
DIS-14 (A d justm ent D isorder)
•  Danger to  s e lf o r  o thers: The th ird  bu lle t changed to  “ C onsider rem oving aharp dangerous ob jec ts ” .
DIS-18 (Substance-Related D isorder/Abuse)
•  Fourth co lum n: The recom m endation changed to  “ Referral to  specia lized trea tm ent p rogram s” .
DIS-19 (Persona lity D isorder)
•  Evaluation: The fo llow ing  bu lle ts were c la rified  as fo llow s, “ Threatening behav io r: D ram atic /h is trion ic  behav io r: Dem anding behavior” . 
DIS-24 (Chaplaincy S ervices: G uilt)
•  Footnote “ h” : “ Referral to  c le rgy o f pe rson ’s fa ith ”  changed to  “ C onsider referra l to  com m un ity  re lig ious resource” .
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®. UPDATES
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“ DISTRESS”
Term “ d is tre ss ” was chosen because i t :
•  Is m ore acceptable and less s tigm atiz ing  than “ psych ia tric ,”  
“ psychosoc ia l,” o r “ em o tiona l”
•  S ounds “ no rm a l”  and less em barrassing
•  Can be defined and m easured by self-report.
D e fin ition  o f D istress in Cancer (DIS-2)
Note: A ll recom m endations are category 2A unless otherwise indicated.
C lin ical Trials: N CCN  believes that the best management of any can cer patient is in a clin ical trial. Participation in clin ical trials is especially  encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®. DIS-1
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DEFINITION OF DISTRESS IN CANCER
D istress is a m u ltifac to ria l unpleasant em otional experience o f a psycho log ica l (cognitive, behavioral, 
em otional), socia l, and/or sp ir itua l nature tha t may in terfere w ith  the a b ility  to  cope e ffec tive ly  w ith  cancer, 
its  physica l sym ptom s and its treatm ent. D istress extends a long a con tinuum , ranging from  com m on  
norm al fee lings o f vu lnerab ility , sadness, and fears to  prob lem s th a t can becom e d isab ling , such as 
depression, anxiety, panic, socia l iso la tion , and exis tentia l and sp iritua l cris is .
Note: A ll recom m endations are category 2A unless otherwise indicated.
C lin ical Trials: N CCN  believes that the best management of any can cer patient is in a clin ical trial. Participation in clin ical trials is especially  encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines"'and this illustration may not be reproduced in any form without the express written permission of NCCN®.
Standard o f Care fo r  D istress Managem ent IDIS-3)
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STANDARDS OF CARE FOR DISTRESS MANAGEMENT
• D istress sho u ld  be recognized, m onitored, docum ented, and treated p rom ptly  at all s tages o f disease and in  all settings.
• Screening shou ld  id en tify  the  level and nature o f the  d is tress.
• A ll pa tien ts shou ld  be screened fo r d is tress at th e ir  in itia l v is it, at appropria te  in tervals, and as c lin ica lly  ind ica ted especia lly w ith  
changes in disease sta tus (ie, rem iss ion , recurrence, progression).
• Distress should be assessed and managed according to clinical practice guidelines.
• In te rd isc ip lina ry  in s titu tion a l com m ittees should be form ed to  im plem ent standards fo r  d is tress management.
• Educational and tra in ing  program s shou ld  be developed to  ensure tha t health care pro fess iona ls  and certified  chap la ins have 
know ledge and s k ills  in the  assessm ent and m anagem ent o f d istress.
■ L icensed mental health pro fess iona ls  and certified  chapla ins experienced in psychosocia l aspects o f cancer shou ld  be readily  
available as s ta ff m em bers o r by referral.
•  Medical care con trac ts  shou ld  inc lude re im bursem ent fo r serv ices provided by mental health pro fessionals.
•  C lin ica l health ou tcom es m easurem ent shou ld  include assessm ent o f the  psychosoc ia l dom ain (eg, qu a lity  o f life and patien t and 
fam ily  satisfaction).
•  Patients, fam ilies, and trea tm ent team s shou ld  be in fo rm ed tha t m anagem ent o f d is tress  is an in tegra l part o f to ta l m edical care and  
provided w ith  appropria te  in fo rm ation  abou t psychosoc ia l serv ices in the  trea tm ent cen ter and the com m unity.
■ Q ua lity  o f d is tress m anagem ent program s/serv ices shou ld  be inc luded in in s titu tion a l con tinuous  qua lity  im provem ent (CQI) projects.
Note: A ll recom m endations are category 2A unless otherwise indicated.
C lin ical Trials: N CCN  believes that the best management of any can cer patient is in a clin ical trial. Participation in clin ical trials is especially  encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®.
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EXPECTED DISTRESS 
SYMPTOMS
•  P atients at increased r isk  o f
vu lne rab ility  to  d is tre ss3
•  S igns and sym ptom s o f fear
and w orry  about the  fu tu re
and uncertainty
> C oncerns abou t illness
> Sadness abou t loss o f 
usual health
> Anger, fee ling ou t o f 
con tro l
> Poor s leep
> Poor appetite
> Poor concen tra tion
> Preoccupation w ith  
tho ugh ts  o f illness and 
death
> Disease o r trea tm ent side  
effects
> C oncerns abou t socia l role 
(ie, as father, m other)
INTERVENTIONS
• Clarify diagnosis, treatment options 
and side effects
► Be sure patient understands 
disease and treatment options
► Refer to appropriate patient 
education materials (eg, NCCN 
Treatment Summaries for Patients)
• Educate patient that points of 
transition may bring increased 
vulnerability to distress
• Acknowledge distress
■ Build trust
• Ensure continuity of care
■ Mobilize resources
• Consider medication to manage 
symptoms:
► A na lgesics
(See NCCN Adult Cancer Pain 
Guidelines)
► Anxiolytics
► Hypnotics
► Antidepressants
■ Support groups and/or individual 
counseling
■ Family support and counseling
• Relaxation, meditation, creative 
therapies (eg, art, dance, music)
• Spiritual support
• Exercise
RE-EVALUATION
Stable o r
d im in ished --------►
d is tress
Continue  
m on ito ri ng 
and sup po rt
M on itor 
func tiona l level 
and reevaluate  
at each v is it
Increased o r
pe rs is ten t
d is tress
See D istress
Score > 4 o r
m oderate to
severe d is tress
(DIS-4)
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SCREENING TOOLS FOR MEASURING DISTRESS
In s tru c tio n s : F irs t p lease c irc le  the  num ber (0-10) th a t best 
d e sc rib e s  how  m uch d is tre s s  you  have been e xp e rie n c in g  in 
th e  pa s t w eek in c lu d in g  today.
Extreme distress
No distress
10
9  _  
8
7  
6 
5  —
4  
3  
2 
1 —
O
°o
Second, please indica te if  any o f the fo llow ing  has been a 
problem  fo r  you in the past week inc lud ing  today. Be sure to  
check YES o r NO fo r each.
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
a
□
□
□
□
□
□
a
□
□
□
□
□
□ □
Child care □ □ Appearance
Housing □ □ Bathing/dressing
insurance/financial □ □ Breathing
Transportation □ □ Changes in urination
W ork/school □ □ Constipation
Treatment decisions □ □ Diarrhea
□ □ Eating
Familv Problems □ □ Fatigue
Dealing with children □ □ Feeling Swollen
Dealing with partner a a Fevers
Ability to have children □ a Getting around
Family health issues □ □ Indigestion
Emotional Problems
□ □ M em ory/concentration
□ □ Mouth sores
Depression
Fears
□ a N a u s e a
□ □ Nose dry/congested
Nervousness □ □ Pain
Sadness □ □ Sexual
Worry
□ □ Skin dry/itchy
Loss of interest in 
usual activities □ □ Sleep
□ □ Substance abuse
Soiritual/reliaious □ □ Tingling in hands/feet
con ce rn s  
O th e r P rob lem s:
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®. DIS-A
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PSYCHO SO CIAL D ISTRESS PATIENT CH A RA CTERISTICS0
PATIENTS AT INCREASED RISK FOR D ISTR ESS”
•  H istory o f psych ia tric  d isorder/substance abuse
•  H istory o f depression /su ic ide  attem pt
•  C ogn itive  im pairm ent
•  C om m unication b a rrie rse
•  Severe com orb id  illnesses
•  Socia l issues
► Fam ily/careg iver con flic ts
► Inadequate socia l suppo rt
► L iv ing  alone
► Financial problem s
► Lim ited access to  m edical care
► Young o r dependent ch ild ren
► Younger age; wom an
>■ H istory o f abuse (physica l, sexual)
► O ther s tressors
•  S p iritua l/re lig ious  concerns
•  U ncon tro lled  sym ptom s
PERIODS OF INCREASED VULNERABILITY
• Finding a suspicious symptom
• During diagnostic workup
• Finding out the diagnosis
• Awaiting treatment
• Change in treatment modality
• End of treatment
• Discharge from hospital following treatment
• Transition to survivorship
• Medical follow-up and surveillance
• Treatment failure
• Recurrence/progression
• Advanced cancer
• End of life
cFor site-specific symptoms with major psychosocial consequences, see Holland, JC, G reenberg, DB, Hughes, MD, et al. Quick Reference for Oncology Clinicians: 
The Psychiatric and Psychological D imensions of Cancer Symptom Management. (Based on the NCCN Distress Management Guidelines). IPOS Press, 2006 
Available at www.aoos-societv.ora. 
dFrom the NCCN Palliative Care Clinical Practice Guidelines in Oncology, Available at www.nccn.ora.
^Comm unication barriers include language, literacy, and physical barriers.
Note: A ll recom m endations are category 2A unless otherwise indicated.
C lin ical Trials: N CCN  believes that the best management of any can cer patient is in a clin ical trial. Participation in clin ical trials is especially  encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines"' and this illustration may not be reproduced in any form without the express written permission of NCCN®. DIS-B
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SOCIAL WORK 
AND COUNSELING 
SERVICES 9
Referral by
oncology
team
to social
work
and
counseling
services
CATEGORY TYPE OF PROBLEM
• Illness-related problems
■ Concrete needs, including 
housing, food, financial 
assistance programs, 
assistance with activities
Practical _ of daily living,
problems transportation
Employment/school/career 
concerns
Cultural/language issues 
Family and caregiver 
availability
/
\
Severe/ _ 
moderate
Mild ■
_ Patient/family/ 
assessment
PsychosociaJ_
problems
■ Adjustment to  illness
• Family and social 
conflict/isolation
•  Treatment decisions, quality- 
of-life issues, and transitions 
in care
• Advance directive
•  Abuse and neglect
•  Coping/communication
•  Functional changes including 
body image and sexuality
•  End of life/bereavement
•  Cultural concerns
•  Caregiver issues 
(mobilizing caregiver 
support)
> Patient/family education 
■ Education/support group sessions 
M ild ---------► •  Resource lists
• Sex counseling
• Grief counseling
SSocial work and counseling services include mental health services using psychological/psychiatric treatment guidelines.
Severe/ _ 
moderate
SOCIAL WORK AND COUNSELING
INTERVENTIONS
• Patient and family 
counseling/psychotherapy
• Community resource 
mobilization/linkage
• Problem-solving teaching
• Advocacy and patient/family 
education
• Patient/family education
• Education/support group sessions
• Resource lists
• Patient and family 
counseling/psychotherapy, sex 
counseling, and grief counseling
• Community resource mobilization
• Problem-solving teaching
• Advocacy and family/patient 
education
• Education/support group 
sessions
• Protective services
• Consider referral for 
psychosocial/psychiatric 
treatment
• Consider referral for chaplaincy 
counseling
Follow-up and 
communication 
with primary 
oncology team 
and family/ 
caregivers
Note: A ll recom m endations are category 2A unless otherw ise indicated.
C lin ica l Trials: NCCN believes tha t the  best management of any cancer patient is in a c lin ica l tria l. Partic ipation in c lin ica l tria ls  is especially encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines" and this illustration may not be reproduced in any form without the express written permission of NCCN®.
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RECOMMENDATIONS FOR IMPLEMENTATION OF STANDARDS AND GUIDELINES
• Encourage establishment of institutional interdisciplinary committees fo r implementation of standards and guidelines
• Conduct muiticenter tria ls that explore brief screening instruments and pilot treatment guidelines
• Encourage institutional CQI (continuous quality improvement) projects in quality of distress management
■ Develop educational approaches to  distress management fo r staff, patients, and family
RECOMMENDED READINGS FOR IMPLEMENTATION OF PROGRAMS THAT INTEGRATE 
PSYCHOSOCIAL CARE INTO THE ROUTINE CARE OF PATIENTS WITH CANCER
• Bultz BD, Groff SL, Fitch M, et al. Implementing screening fo r 
distress, the 6th vita l sign: a Canadian strategy fo r changing 
practice. Psychooncology 2011;20:463-469. Available at: 
http://www.ncbi.nlm.nih.gov/Dubmed/21456060.
•  Carlson LE, Waller A, Mitchell AJ. Screening fo r distress and unmet 
needs in patients w ith cancer: review and recommendations. J Clin 
Oncol 2012;30:1160-1177. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22412146.
•  Dolbeault S, Boistard B, Meuric J, et al. Screening fo r distress and 
supportive care needs during the initial phase o f the care process: 
a qualitative description o f a clin ical p ilot experiment in a French 
cancer center. Psychooncology 2011 ;20:585-593. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21425386.
• Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer 
services. J Clin Oncol 2012;30:1178-1186. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22412139.
•  Frost GW, Zevon MA, Gruber M, Scrivani RA. Use o f distress 
thermometers in an outpatient oncology setting. Health Soc Work 
2011;36:293-297. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22308881.
•  Fulcher CD, Gosselin-Acomb TK. Distress assessment: practice 
change through guideline implementation. Clin J Oncol Nurs 
2007;11:817-821. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/18063540.
•  Grassi L, Rossi E, Caruso R, et al. Educational intervention in cancer 
outpatient clin ics on routine screening fo r emotional distress: an 
observational study. Psychooncology 2011;20:669-674. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21370316.
•  Hendrick SS, Cobos E. Practical model fo r psychosocial care. J Oncol 
Pract 2010;6:34-36. Available at:
http ://www. ncbi. nlm ,ni h. gov/pubmed/20539730.
•  Loscalzo M, Clark KL, Holland J. Successful strategies fo r 
implementing biopsychosocial screening. Psychooncology 
2011;20:455-462. Available at:
http ://www. ncbi. nlm ,ni h. gov/pubmed/21456059.
•  Lowery AE, Holland JC. Screening cancer patients fo r 
distress:guidelines fo r routine implementation. Community Oncology 
2011;8:502-505. Available at:
http://www.communitvoncoloav.net/fileadmin/content images/co/articl
es/0811502.pdf.
•  Mehta A, Hamel M. The development and impact o f a new 
Psychosocial Oncology Program. Support Care Cancer 2011;19:1873- 
1877. Available at: http://www.ncbi.nlm.nih.aov/pubmed/21681386.
■ Rodriguez MA, Tortorella F, St John C. Improving psychosocial care 
fo r improved health outcomes. J Healthc Qual 2010;32:3-12. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/20618566.
Note: A ll recom m endations are category 2A unless otherw ise indicated.
C lin ica l Trials: NCCN believes tha t the  best m anagement of any cancer patient is in a c lin ica l tria l. Partic ipation in c lin ica l tria ls  is especia lly encouraged.
Version 2.2013,10/11/12© National Comprehensive Cancer Network. Inc. 2012, A l rights reserved. The NCCN Guidelines"' and this illustration may not be reproduced in any form without the express written permission of NCCN®. DIS-28
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■ Interdisciplinary committee ta ilors 
standards to institutional setting
• Screening tool (0-10) in clinics 
and inpatient setting
■ Problem list
•  Education of primary oncology 
teams via rounds and liaison w ith 
nurses and social workers
• C larification o f resources access 
(psychological, social, religious)
•  CQI studies
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NCCN Categories of Evidence and Consensus
Category 1: Based upon high-level evidence, there is uniform NCCN 
consensus that the intervention is appropriate.
Category 2A: Based upon lower-level evidence, there is uniform 
NCCN consensus that the intervention is appropriate.
Category 2B: Based upon lower-level evidence, there is NCCN 
consensus that the intervention is appropriate.
Category 3: Based upon any level of evidence, there is major NCCN 
disagreement that the intervention is appropriate.
A ll recommendations are category 2A unless otherwise noted.
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Overview
In the United States, it is estimated that a total of 1,638,910 new cancer 
cases and 577,190 deaths from cancer will occur in 2012.1 All patients 
experience some level of distress associated with the diagnosis of 
cancer and the effects of the disease and its treatment regardless of 
the stage of disease. Distress can result from the reaction to the 
diagnosis of cancer and to the various transitions throughout the 
trajectory of the disease including during survivorship. Clinically 
significant levels of distress occur in a subset of patients, and 
identification and treatment of distress are of the utmost importance.
These NCCN Distress Management guidelines discuss the 
identification and treatment of psychosocial problems in patients with 
cancer. They are intended to assist oncology teams identify patients 
who require referral to psychosocial resources and to give oncology 
teams guidance on interventions for patients with mild distress. These 
guidelines also provide guidance for social workers, certified chaplains, 
and mental health professionals that describe treatments and 
interventions for various psychosocial problems as they relate to 
patients with cancer.
Psychosocial Problems in Patients with Cancer
In the past two decades, dramatic advances in early detection and 
treatment options have increased the overall survival rates in patients 
of all ages with cancer. At the same time, these improved treatment 
options are also associated with substantial long-term side effects: 
fatigue, pain, anxiety, and depression are the most frequently reported 
cancer-related symptoms that interfere with the patient's ability to 
perform daily activities.2 In addition, the physiologic effects of cancer 
itself and certain anti-cancer drugs can also be non-psychological 
contributors to distress symptoms.3-6 Furthermore, cancer patients may
have pre-existing psychological or psychiatric conditions that impact 
their ability to cope with cancer.
The prevalence of psychological distress in individuals varies by the 
type and stage of cancer as well as by patient age. In a study of 4496 
cancer patients, Zabora and colleagues reported that the overall 
prevalence of distress was 35,1%, which varied from 29.6% for patients 
with gynecological cancers to 43.4% for patients with lung cancer.7 The 
prevalence of distress, depression, and psychiatric disorders has been 
studied in many sites and stages of cancer.814 Overall, surveys have 
found that 20-47% of newly diagnosed and recurrent cancer patients 
show a significant level of distress. A recent metaanalysis reported that 
30-40% of patients with various types of cancer have some 
combination of mood disorders.15
Patients at increased risk for moderate or severe distress are those 
with a history of psychiatric disorder, depression, or substance abuse 
and those with cognitive impairment, severe comorbid illnesses, 
uncontrolled symptoms, communication barriers, or social issues.
Social issues/risk factors include younger age; female; living alone, 
having young children, and prior physical or sexual abuse.
Distress is a risk factor for non-adherence to treatment, especially with 
oral medications. In women with primary breast cancer, Partridge and 
colleagues observed that the overall adherence to tamoxifen decreased 
to 50% in the fourth year of therapy and nearly one fourth of patients 
may be at risk of inadequate clinical response due to poor adherence.16 
In a meta-analysis, DiMatteo and colleagues found that noncompliance 
was 3 times greater in depressed patients as compared to non­
depressed patients.17 in addition to decreased adherence to treatment, 
failure to recognize and treat distress leads to several problems: 
patients may have trouble making decisions about treatment and they
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may make extra visits to the physician's office and emergency room, 
which takes more time and causes greater stress for the oncology 
team.1819 Distress in patients with cancer also leads to poorer quality of 
life and can even negatively impact survival.14'20,21 Furthermore, cancer 
survivors with untreated distress have poorer compliance with 
surveillance screenings and are less likely to exercise and quit 
smoking.22
Early evaluation and screening for distress leads to early and timely 
management of psychological distress, which in turn improves medical 
management.23,24 A recent randomized study showed that routine 
screening for distress, with referral to psychosocial resources as 
needed, led to lower levels of distress at 3 month than did screening 
without personalized triage for referrals.25 Those with the highest level 
of initial distress benefited the most. In addition, there is evidence from 
randomized trials that psychologically effective interventions may lead 
to a survival advantage in patients with cancer.26 Overall, early 
detection and treatment of distress leads to
• better adherence to treatment
• better communication
• fewer calls and visits to the oncologist's office
■ avoidance of patients’ anger and development of severe anxiety or 
depression
Barriers to Distress Management in Cancer
Less than half of distressed patients with cancer are actually identified 
and referred for psychosocial help,27,28 Many patients with cancer who 
are in need of psychosocial care are not able to get the help they need 
due to the under-recognition of patient's psychological needs by the 
primary oncology team and lack of knowledge of community 
resources.29 The need is particularly acute in community oncologists’
practices where there are few to no psychosocial resources, and 
cancer care is often provided by short visits.
An additional barrier to patients receiving the psychosocial care they 
require is the stigma associated with psychological problems. For many 
centuries, patients were not told their diagnosis of cancer due to the 
stigma attached to the disease. Since the 1970s, this situation has 
changed and patients are well aware of their diagnosis and treatment 
options.30 However, patients are reluctant to reveal emotional problems 
to the oncologist. The words “psychological," "psychiatric,” and 
“emotional” are as stigmatizing as the word “cancer.” The word 
“distress" is less stigmatizing and more acceptable to patients and 
oncologists than these terms, but psychological issues remain 
stigmatized even in the context of coping with cancer. Consequently, 
patients often do not tell their physicians about their distress and 
physicians do not inquire about the psychological concerns of their 
patients. The recognition of patients’ distress has become more difficult 
as cancer care has shifted to the ambulatory setting, where visits are 
often short and rushed. These barriers prevent distress from receiving 
the attention it deserves, despite the fact that this is a critical 
component of the total care of the person with cancer.
NCCN Guidelines® for Distress Management
A major milestone in the improvement of psychosocial care in oncology 
was made by the NCCN when it established a panel to develop clinical 
practice guidelines, using the NCCN format. The panel began to meet 
in 1997 as an interdisciplinary group. The clinical disciplines involved 
were: oncology, nursing, social work and counseling, psychiatry, 
psychology, and clergy, A patient advocate was also on the panel. 
Traditionally, clergy have not been included on NCCN guideline panels,
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but the NCCN recognized that many distressed patients prefer a 
certified chaplain.31
The first step was to understand why this area has been so difficult to 
develop. The panel members decided that words like "psychiatric" or 
"psychological” are stigmatizing; patients and oncologists are reluctant 
to label any symptoms or patients as such. The way around this barrier 
was developed by using a term that would feel ‘‘normal" and 
non-stigmatizing This led to the first published guidelines in 1999 for 
the management of distress in cancer patients. This accomplishment 
provided a benchmark, which has been used as the framework in the 
handbook for oncology clinicians published by the IPOS press (The 
International Psycho-Oncology Society).31
The panel defines distress as a multifactorial unpleasant emotional 
experience of a psychological (cognitive, behavioral, emotional), social, 
and/or spiritual nature that may interfere with the ability to cope 
effectively with cancer, its physical symptoms, and its treatment. 
Distress extends along a continuum, ranging from common normal 
feelings of vulnerability, sadness, and fears to problems that can 
become disabling, such as depression, anxiety, panic, social isolation, 
and existential and spiritual crisis.
Recommendations in the guidelines are based on evidence and on 
consensus among panel members. In addition to the guidelines for 
oncologists, the panel established guidelines for social workers, 
certified chaplains, and mental health professionals (psychologists, 
psychiatrists, psychiatric social workers, and psychiatric nurses).33
The New Standard of Care for Distress Management in 
Cancer
Psychosocial care had not been considered as an aspect of quality 
cancer care until a 2007 Institute of Medicine (IOM) report, C ancer  
C are  for the W hole P atient.34 The IOM report is based on the 
pioneering work of the NCCN panel, which recommends screening for 
distress and the development of a treatment plan with referrals as 
needed to psychosocial resources.33 Psychosocial care is now a part of 
the new standard for quality cancer care and should be integrated into 
routine care,34 35 The IOM report supported the work of the NCCN 
Guidelines for Distress Management by proposing a model for the 
effective delivery of psychosocial health services that could be 
implemented in any community oncology practice:
•  Screening for distress and psychosocial needs
• Making a treatment plan to address these needs and implementing it
•  Referring to services as needed for psychosocial care
• Reevaluating, with plan adjustment as appropriate.
In Canada, routine psychosocial care is part of the standard of care for 
patients with cancer; emotional distress is considered the sixth vital 
sign that is checked routinely along with pulse, respiration, blood 
pressure, temperature, and pain.18,36
In August 2012, the Commission on Cancer (CoC) of the American 
College of Surgeons (ACS) released new accreditation standards for 
hospital cancer programs
(’http://www.facs org/cancer/coc/programsta ndards2012.html"], Their 
patient-centered focus now includes screening all patients with cancer 
for psychosocial distress.
The standards of care for managing distress proposed by the NCCN 
Distress Management panel are broad in nature and should be tailored
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to the particular needs of each institution and group of patients. The 
overriding goal of these standards is to ensure that no patient with 
distress goes unrecognized and untreated. The panel based these 
standards of care on quality improvement guidelines for the treatment 
of pain.37 The standards of care developed by the NCCN Distress 
Management panel, which can also be found in the guidelines, are:
• Distress should be recognized, monitored, documented, and treated 
promptly at all stages of disease and in all settings.
■ Screening should identify the level and nature of the distress.
• All patients should be screened to ascertain their levels of distress at 
the initial visit, at appropriate intervals, and as clinically indicated, 
especially with changes in disease status (remission, recurrence, or 
progression).
• Distress should be assessed and managed according to clinical 
practice guidelines.
• Interdisciplinary institutional committees should be formed to 
implement standards for distress management.
• Educational and training programs should be developed to ensure 
that health care professionals and certified chaplains have knowledge 
and skills in the assessment and management of distress.
• Licensed mental health professionals and certified chaplains 
experienced in the psychosocial aspects of cancer should be readily 
available as staff members or by referral,
• Medical care contracts should include reimbursement for services 
provided by mental health professionals.
• Clinical health outcomes measurements should include assessment 
of the psychosocial domain (eg, quality of life and patient and family 
satisfaction).
• Patients, families, and treatment teams should be informed that 
management of distress is an integral part of total medical care and
provided with appropriate information about psychosocial services in 
the treatment center and in the community.
» Finally, the quality of distress management programs/services should 
be included in institutional continuous quality improvement (CQI) 
projects.
Patients and families should be made aware that this new standard 
exists and that they should expect it in their oncologist's practice. The 
Alliance (http://www.wholecancerpatient.org/) is a coalition of 
professional and advocacy organizations whose goal is to advance the 
recommendations from the IOM report. Their website has hundreds of 
psychosocial resources for health care professionals, patients, and 
caregivers, searchable by state.
Recommendations for Implementation of Standards 
and Guidelines
Jacobsen and colleagues conducted a study in 2005 evaluating the 
implementation of NCCN Guidelines for Distress Management by 15 
NCCN member institutions.38 Eight institutions (53%) conducted routine 
distress screening of some patient populations and an additional 4 
institutions (27%) also preformed pilot testing of screening strategies. 
However, concordance to NCCN Guidelines (screening all patients) 
was observed in only 20% of the member institutions at that time.
Implementation of the IOM standards for integration of psychosocial 
care into the routine care of patients with cancer can be improved by 
providing feedback to oncology practices on the quality of their 
psychosocial care. Quality indicators were thus developed by Jacobsen 
and colleagues. They developed a patient chart audit which permits an 
oncologists’ office or clinic to evaluate the quality of their psychosocial 
care.39 The survey queries whether there is documentation that the 
patient’s current emotional well-being was assessed and if there is
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documentation that any action was taken if the patient was identified as 
having a problem. These quality indicators can be used widely to 
determine the quality of psychosocial care given by a clinic or office.
The Quality Oncology Practice Initiative (QOPI) was started in 2002 by 
the American Society of Clinical Oncology (ASCO) as a pilot project 
(http://qopi.asco.org/proqram.htmn.40 This program became available to 
all ASCO member medical oncologists in 2006. Jacobson’s 
psychosocial quality indicators were added as part of the core 
measures in the QOPI quality measures in 200841 in a recent analysis, 
Jacobson and colleagues reported that practices participating in QOPI 
demonstrated improved performance, with initially low-performing 
practices showing the greatest improvement.41 Blayney and colleagues 
from the University of Michigan Comprehensive Cancer Center recently 
reported that QOPI can be adapted for use in practice improvement at 
an academic medical center.42 The American Psychosocial Oncology 
Society (APOS) has also adopted these quality indicators.43
The panel encourages the establishment of institutional interdisciplinary 
committees to implement and monitor distress management. The 
interdisciplinary committee should be responsible for evaluation of 
standard care in distress management with continuous quality 
improvement (CQI) studies. The panel encourages interdisciplinary CQI 
studies to assess the quality of distress management programs as well 
as the efficacy of standards of care and implementation of these NCCN 
Guidelines for Distress Management and the new quality standard 
established by the IOM report.34 The new CoC accreditation standards 
for hospital cancer programs include screening all patients with cancer 
for psychosocial distress, so psychosocial care is now on all institutions’ 
report cards.
Multicenter randomized trials and pilot testing are needed to compare 
the efficacy of brief screening instruments. Educational approaches 
should be developed for medical staff, patients, and caregivers to 
increase their awareness of the prevalence of distress and of 
psychological interventions.
The MD Anderson Cancer Center published a report on their efforts to 
implement the integration of psychosocial care into clinical care.44 The 
authors outline strategies they used to accomplish the required cultural 
shift and describe the results of their efforts. Other groups have also 
described their efforts towards implementing psychosocial screening in 
various outpatient settings.43'45 Additional guidance for the 
implementation of the new IOM standards has been published.30"52 In 
Canada, a national approach has been used to implement screening for 
distress. Their strategies have been described.53 Groups in Italy and 
France have also described results of their preliminary efforts toward 
the implementation of psychosocial distress screening.54 ”  A reading list 
for implementation of programs that integrate psychosocial care into the 
routine care of patients with cancer is provided in these guidelines.
Overall, to implement the new standard of integrating psychosocial care 
into the routine care of all patients with cancer, it is critical to have a 
fast and simple screening method that can be used to identify patients 
who require psychosocial care and/or referral to psychosocial 
resources.52 The NCCN Distress Management panel developed such a 
rapid screening tool, as discussed below.
Screening Tools for Distress and Meeting Psychosocial 
Needs
Identification of a patient's psychological needs is essential to develop 
a plan to manage those needs. Ideally, patients tell their oncologists 
about their problems or they respond to the oncologist’s query about
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them. In routine clinical practice, time constraints and the stigma related 
to psychiatric and psychological needs often leads to no discussion of 
these issues. Screening tools have been found to be effective and 
feasible in reliably identifying distress and the psychosocial needs of 
patients.56-58 Mitchell and colleagues recently reported that ultra-short 
methods (PHQ2 or the Distress Thermometer) were acceptable to 
about three quarters of clinicians.59’60 Automated touch-screen 
technologies have also been used for psychosocial screening of 
patients with cancer.61-62 Recently, an internet-based program that 
includes distress screening, reporting, referrals, and followup 
components has been developed. The screening component was 
validated in a trial of 319 community-based cancer survivors and 
showed good psychometric properties.63
A recent metaanalysis compared 8 tools designed to screen for 
depression in the cancer setting that had been validated by at least 2 
separate studies.64 This analysis included the Hospital Anxiety and 
Depression Scale (HADS), the Beck Depression Inventory version 2 
(BDI-ll), and the Distress Thermometer (DT, discussed below).
The Distress Thermometer (DT)
The NCCN Distress Management panel developed the distress 
thermometer (DT), a now well known tool for initial screening, which is 
similar to the successful rating scale used to measure pain: 0 (no 
distress) to 10 (extreme distress). The DT serves as a rough initial 
single-item question screen, which identifies distress coming from any 
source, even if unrelated to cancer. The receptionist gives it to the 
patient in the waiting room.
The word "distress” was chosen as described above, because it is less 
stigmatizing and more acceptable to patients and oncologists than 
other terms such as psychiatric, psychosocial, or emotional. Using this
non-stigmatizing word diminishes clinicians' concerns that the patient 
will be embarrassed or offended by these questions. Asking an 
objective question such as, “How is your pain today on a scale of 0 to 
10?" made it easier and more comfortable for caregivers to learn about 
patients' pain. Similarly, asking patients, “How is your distress today on 
a scale of 0 to10?” opens a dialogue with the oncologist or nurse for a 
discussion of emotions that is more acceptable.
The patient in the waiting room places a mark on the DT scale 
answering: "How distressed have you been during the past week on a 
scale of 0 to 10?” Scores of 4 or higher suggest a level of distress that 
has clinical significance. If the patient's distress level is mild (score is 
less than 4 on the DT), the primary oncology team may choose to 
manage the concerns by usual clinical supportive care management. If 
the patient’s distress level is 4 or higher, the nurse looks at the problem 
list (see below) to identify key issues of concern and asks further 
questions to determine to which resources (mental health, social work 
and counseling, or chaplaincy services) the patient should be referred.
The DT has been validated by several studies in patients with different 
types of cancer and has revealed concordance with the Hospital 
Anxiety and Distress Scale (HADS).56,65'71 The DT has shown good 
sensitivity and specificity. The needs assessment surveys performed in 
ambulatory clinics using these screens show 20-40% of patients have 
significant levels of distress. Two studies validated a version of the DT 
with an expanded problems list.7273 Tuinman and colleagues validated 
the DT with the 46-item problem list in a cross-sectional group of 227 
cancer patients.73 Graves and colleagues validated the DT with an 
adapted problems list with two new problem categories (information 
concerns and cognitive problems) in lung cancer patients.72 The DT is 
also a useful tool for screening distress among bone marrow transplant 
patients.74'75 The DT had acceptable overall accuracy and greater
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sensitivity and specificity when compared to the Center for 
Epidemiological Studies-Depression Scale (CES-D) in the assessment 
of depression in patients undergoing bone marrow transplants.74
The Problem List
The screening tool developed by the NCCN Distress Management 
panel includes a 39-item Problem List, which is on the same page with 
the DT. The Problem List asks patients to identify their problems in five 
different categories: practical, family, emotional, spiritual/religious, and 
physical (see Screening Tools for Measuring Distress in the guidelines). 
The completed list is reviewed by the nurse, because he/she is present 
at all visits and is the likely person to ask clarifying questions. Social 
workers are often not immediately available in busy clinics.
Cognitive Im pairm ent
'Memory/concentration problems” is one item on the Problem List. 
Cognitive impairment is common in patients with primary central 
nervous system (CNS) cancers, due to both the effects of brain tumors 
themselves and the effects of treatment targeted to the brain.76,77 
Recent evidence has shown that chemotherapy-related cognitive 
dysfunction is also prevalent in patients with non-CNS cancers and 
without brain metastases.78'31 Chemotherapy can cause subtle cognitive 
changes, studied primarily in breast and lymphoma patients. It can 
continue over years and at times, when more severe, can impact 
quality of life and function. The underlying mechanisms for 
chemotherapy-induced cognitive changes are not known. Recent 
studies have reported elevated levels of cytokines or DNA damage as 
some of the possible mechanisms.81 In addition, evidence suggests that 
cancer itself and therapies other than chemotherapy, such as hormone 
therapy, can cause cognitive impairments in patients with cancer.83'86 A 
recent national cross-sectional study found that a history of cancer is 
independently associated with a 40% increase in the likelihood of self­
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reported memory problems.87 A better understanding of the 
mechanisms that cause cancer-related cognitive impairment is 
essential for the development of treatments to improve cognitive 
function and quality of life in patients with cancer.76,77,88
There is no standard treatment for the management of cognitive 
changes in patients with cancer. Cognitive behavior therapy, cognitive 
rehabilitation programs, and exercise may be effective interventions to 
improve cognitive function in patients with cancer8990 In addition, some 
studies have shown that the use of psychostimulants such as 
methylphenidate and modafinil improved cognitive function in patients 
with cancer.91'93 Donepezil, a reversible acetylcholinesterase inhibitor 
(approved to treat mild to moderate dementia in patients with 
Alzheimer’s disease) also improved cognitive function, mood, and 
health-related quality of life in patients with primary low-grade glioma.94 
Further placebo controlled trials are needed to confirm these 
preliminary findings.
In October 2006 the International Cognition and Cancer Task Force 
(ICCTF), comprised of a multidisciplinary group of health professionals 
and health advocates, was formed. The mission of ICCTF is to advance 
understanding of the impact of treatment-related cognitive and 
behavioral functioning in patients with non-CNS cancers.’5 ICCTF also 
has a web site (www.icctf.com1 to provide up-to-date information to 
both physicians and patients seeking assistance in the management of 
cognitive symptoms associated with cancer treatment.
Fertility
Another item on the Problem List is the “ability to have children." 
Chemotherapy and radiation therapy also have an impact on the fertility 
of patients, especially in those who are of child-bearing age.96 
Therefore, the panel has included “ability to have children" as one of
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the items under the family problems category. MvOncofertilitv.org is a 
useful patient education resource for those who are concerned about 
the possible effect of cancer treatment on their fertility.
Sujbsfance Abuse
For the 2013 version of these guidelines, the panel added substance 
abuse to the list of possible physical problems. Substance abuse in 
patients with cancer who do not have a history of abuse or addiction is 
rare and is usually caused by insufficient symptom control. Improving 
symptom control often alleviates the substance dependence. This 
problem is discussed in more detail below in Substance-Related 
Disorder/Abuse.
Initial Evaluation and Treatment by Oncology Team
The panel recommends that all patients be assessed in the waiting 
room using a simple screening tool. While there are several types of 
screening tools, the DT and the accompanying Problem List are 
recommended to assess the level of distress and to identify causes of 
distress. If the patient's distress is moderate or severe (thermometer 
score of 4 or more), the oncology team must recognize that score as a 
trigger to a second level of questions should prompt referral to a mental 
health professional, social worker, or spiritual counselor, depending on 
the problems identified in the Problem List. Common symptoms that 
require further evaluation are: excessive worries and fears, excessive 
sadness, unclear thinking, despair and hopelessness, severe family 
problems, social problems, and spiritual or religious concerns.
Mild distress (DT score of less than 4) is routinely managed by the 
primary oncology team and represents what the panel terms "expected 
distress" symptoms. The symptoms that the team manages are fear, 
worry, and uncertainty about the future; concerns about the illness; 
sadness about loss of good health; anger and the feeling that life is out
of control; poor sleep, poor appetite, and poor concentration; 
preoccupation with thoughts of illness, death, treatment, and side 
effects; and concerns about social roles (eg, as mother, father). Most 
patients experience these symptoms at the time of diagnosis and 
during arduous treatment cycles. They might persist long after the 
completion of treatment. For instance, minor symptoms are often 
misinterpreted by survivors as a sign of recurrence, which causes fear 
and anxiety until they are reassured.
The primary oncology team is the first to deal with these painful 
problems. The oncologist, nurse, and social worker each have a critical 
role. First and foremost is the quality of the physician s communication 
with the patient, which should occur in the context of a mutually 
respectful relationship so that the patient can learn the diagnosis as 
well as understand the treatment options and side effects.57’98 Adequate 
time should be provided for the patient to ask questions and for the 
physician to put the patient at ease. When communication is done well 
at diagnosis, the stage is set for future positive trusting encounters. It is 
important to ensure that the patient mentally grasps what has been 
said. Information may be reinforced with drawings or by taping the 
session and giving the tape to the patient. Communication skills training 
for oncology professionals who teach, for example, how to discuss 
prognosis and unanticipated adverse events and howto reach a shared 
treatment decision may be very helpful. Communication skills training 
was recently reviewed by Kissane et a l."
It is important for the oncology team to acknowledge that this is a 
difficult experience for the patient and that distress is normal and 
expected. Being able to express distress to the staff helps provide relief 
to the patent and builds trust. The team needs to ensure that social 
supports are in place for the patient and that he or she knows about 
community resources such as support groups, teleconferences, and
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, A l  rights reserved. The NCCN Guidelines© and this illustration may not be reproduced in any form without the express written permission o f NCCN®. MS-9
111
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
help lines. The IOM report contains a list of national organizations and 
their toll-free numbers.34 Some selected organizations that provide free 
information services to cancer patients are:
• American Cancer Society (www.cancer.org)
• American Institute for Cancer Research fwww.aicr.org')
• American Psychosocial Oncology Society (www.apos-societv.om) 
(APOS provides a toll-free Help Line [1-866-276-7443] to which 
patients and their caregivers can be referred to help them find 
psychological resources in their community.)
• CancerCare (www.cancercare.ora)
• National Cancer Institute (www.cancer.aov)
• Cancer.net, sponsored by ASCO fwww.cancer.net).
• Cancer Support Community 
(’http://www.cancersuDp0rtc0m m unitv.0rq)
Clinicians should be aware of the evidence-supported interventions 
available for the management of distress. In addition to these NCCN 
Guidelines for Distress Management (www.nccn.oro). the following 
clinical practice guidelines will be useful to clinicians, including the 
oncology team:
• Clinical practice guidelines for the psychosocial care of adults with 
cancer have been developed by the Australian National Breast 
Cancer Centre and the National Cancer Control Initiative 
(h ttp://www .nhm  rc.aov.au/auidelines/Dublications/cD90).
• National Cancer Institute and several partners have developed a web 
site that provides information about research-tested intervention 
programs (http://rtips.cancer gov/rtips/index.do).
Follow-up at regular intervals or at transition points in illness is an 
essential part of the NCCN Guidelines for Distress Management and 
the IOM model for care of the whole patient. This reassessment is 
particularly important in elderly cancer patients.100
Psychological/Psychiatric Treatment by Mental Health 
Professionals
Psychosocial Interventions
Psychosocial interventions have been effective in reducing distress and 
improving overall quality of life among cancer patients.34,35 The 2007 
IOM report noted that there is a strong evidence base that supports the 
value of psychosocial interventions in cancer care.34 The review 
examined the range of interventions (psychological, social, and 
pharmacologic) and their impact on any aspect of quality of life, 
symptoms, or survival. The extensive review found randomized clinical 
trials, systematic reviews, and meta-analyses supporting the conclusion 
that psychosocial aspects must be integrated into routine cancer care in 
order to give quality cancer care. Cognitive-behavioral therapy (CBT), 
supportive psychotherapy, and family and couples therapy are the three 
key types of psychotherapies discussed in the IOM report.34
Cognitive-Behavioral Therapy
CBT involves relaxation, enhancing problem-solving skills, and the 
identification and correction of inaccurate thoughts associated with 
depressed feelings. In randomized clinical trials, CBT has been shown 
to effectively reduce psychological symptoms (anxiety and 
depression)101,182 as well as physical symptoms (pain and fatigue)103 in 
patients with cancer. A recent systematic review, however, concluded 
that data on the efficacy of CBT in patients with advanced cancer is 
lacki ng.104
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Ferguson and colleagues have developed a brief CBT intervention 
(Memory and Attention Adaptation Training [MAAT]) aimed at helping 
breast cancer survivors manage cognitive dysfunction associated with 
adjuvant chemotherapy.105 In this single-arm pilot study, improvements 
in self reporting of cognitive function, quality of life, and standard 
neuropsychological test performance were observed in all patients (29 
women at an average of 8 years after adjuvant chemotherapy for stage 
l-ll breast cancer). The authors have since performed a randomized 
study to evaluate the efficacy of MAAT.89 They found that patients in the 
intervention arm had improved verbal memory performance and 
spiritual well-being.
Supportive Psychotherapy
Supportive psychotherapy, aimed at flexibly meeting patients' changing 
needs, is most widely used. Different types of group psychotherapy 
have been evaluated in clinical trials among cancer patients. 
Supportive-expressive group therapy has been shown to improve 
quality of life and psychological symptoms, especially improvements in 
mood and pain control in patients with metastatic breast cancer. 106-107 
Cognitive-existential group therapy has been found to be useful in 
women with early-stage breast cancer receiving adjuvant 
chemotherapy.108 Meaning-centered group psychotherapy, designed to 
help patients with advanced cancer sustain or enhance a sense of 
meaning, peace, and purpose in their lives (even as they approach the 
end of life), has also been shown to reduce psychological distress 
among patients with advanced cancer.109'110 Recently, dignity therapy 
has been assessed in a randomized controlled trial of patients with a 
terminal diagnosis (not limited to cancer).111 Although there was no 
significant improvement in levels of distress in patients receiving dignity 
therapy as measured by several scales, significant improvements,
specifically for depression and self-reported aspects of quality-of-life, 
were seen.
Fam ily and Couples Therapy
A cancer diagnosis causes distress in partners and family as well as 
the patient. Psychosocial interventions aimed at patients and their 
families together might lessen distress more effectively than individual 
interventions. In a longitudinal study of couples coping with early-stage 
breast cancer, mutual constructive communication was associated with 
less distress and more relationship satisfaction for both the patients and 
partners compared to demand/withdraw communication or mutual 
avoidance, suggesting that training in constructive communication 
would be an effective intervention.112
Family and couples therapy has not been widely studied in controlled 
trials. A small randomized trial was recently reported in which patients 
and their caregivers received 8 emotionally focused therapy sessions or 
standard care.113 Significant improvements in marital functioning and 
patient experience of empathetic care by the caregiver were seen. 
These effects were maintained 3 months after the intervention. In 
addition, a randomized controlled trial showed that family-focused grief 
therapy can reduce the morbid effects of grief in families with terminally 
ill cancer patients.114 A recent systematic review of 23 studies that 
assessed the efficacy of psychosocial interventions for couples affected 
by cancer found evidence that couples therapy might be at least as 
effective as individual therapy.115
Pharmacologic Interventions
Research suggests that antidepressants and antianxiety drugs are 
beneficial in the treatment of depression and anxiety in adult cancer 
patients.116'122 In randomized controlled trials, alprazolam123124 (a 
benzodiazepine) and fluoxetine125126 (a selective serotonin reuptake
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inhibitor [SSRI]) have been effective in improving depressive symptoms 
in cancer patients. SSRIs are widely used for depression and anxiety 
symptoms.
Psychostimulant drugs help in the management of fatigue.1271151 
Methylphenidate is likely effective for the treatment of cancer-related 
fatigue, but additional trials are needed. Wakefulness-promoting agents 
such as modafinil are also commonly used to treat fatigue in patients 
with cancer, but their efficacy remains to be shown conclusively.127
Psychological/Psychiatric Treatment Guidelines
Patients scoring 4 or higher on the DT during any visit to the oncologist 
are referred to the appropriate supportive service (mental health, social 
work and counseling, or chaplaincy services) based on the identified 
problem.
Mental health professionals are expected to conduct a psychological or 
psychiatric evaluation that includes an assessment of the nature of the 
distress, behavior and psychological symptoms, psychiatric history, use 
of medications, pain, fatigue, sleep disturbances, other physical 
symptoms, cognitive impairment, body image and sexuality, and 
capacity for decision making and physical safety. A psychiatrist, 
psychologist, nurse, advanced practice clinician, or social worker may 
perform the evaluation. All of these professionals are skilled in mental 
health assessment and treatment. The Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) 
classification of mental disorders is used to identify the psychological 
and psychiatric disorders that commonly occur in patients with cancer.
The panel has developed evaluation and treatment guidelines for the 
most commonly encountered psychiatric disorders: dementia, delirium 
(encephalopathy), mood disorder, adjustment disorder, anxiety
disorder, substance abuse-related disorder, and personality disorder. 
For the 2012 guidelines, the panel developed new guidelines to 
address psychotic disorder and schizophrenia. Psychotropic drugs are 
recommended throughout the guidelines to treat psychiatric disorders.
It is important to note that these drugs can sometimes interact with 
anticancer therapies and cause adverse effects. A recent article 
reviews some of these interactions and discusses other challenges in 
treating cancer in patients with severe mental illness.130
Dementia and Delirium
Dementia and delirium are cognitive impairments that can severely 
impair the patient’s decision-making capacity. Dementia is a permanent 
cognitive impairment. It is not a common complication of cancer 
treatment, but is often present in elderly patients as a comorbid 
condition.131'132 Dementia can be treated with cognitive rehabilitation, 
with or without medications, though treatment is largely management of 
behavior. Delirium is a short-term cognitive impairment. It is usually 
reversible and occurs in cancer treatment related to any toxic state, and 
it often related to medication, particularly opioids.133 Delirium is 
managed by attention to safety, modification of opioids or other 
medications, neuroleptics, and family support and education.134 The 
United Kingdom’s National Institute for Health and Clinical Excellence 
(NICE) issued detailed guidelines for the diagnosis, prevention, and 
management of delirium.135 In addition, a recent comprehensive review 
in The Journal o f Clinical Oncology Special Series on Psychosocial 
Care in Cancer by Breitbart and Alici136 describes the evidence base for 
recommended pharmacologic and non-pharmacologic treatments for 
delirium in patients with cancer.
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Mood and Adjustment Disorders
Mood disorders such as depression and adjustment disorder (mixed 
anxiety and depressive symptoms) are common in patients with cancer 
and can be debilitating. Patients with uncontrolled mood and 
adjustment disorders can develop suicidal tendencies. The incidence of 
suicide among cancer patients in the United States is twice that of the 
general population.137'13’ Older patients and men with head and neck 
cancer or myeloma seem to have a higher risk of suicide,140
Mood disorder is usually managed with psychotherapy or an 
antidepressant with or without anxiolytics. The evidence for these 
treatments has been described.35,141'143 In particular, a recent review by 
Li et al144 in The Journal o f C linical Oncology Special Series on 
Psychosocial Care in Cancer comprehensively describes the evidence 
for recommended pharmacologic and psychosocial interventions for 
treating depression in patients with cancer. Referral to social work and 
counseling services and chaplaincy services may also be considered 
Patients considered a danger to themselves or others should be 
considered for psychiatric consultation. Increased monitoring is also 
warranted, and the removal of dangerous objects should be 
considered. Psychiatric treatment and hospitalization may sometimes 
be necessary.
Anxiety Disorder
Anxiety occurs at times in most patients with cancer,145 The diagnosis 
of cancer and the effects of the disease and its treatment are obvious 
sources of unease; however, anxiety may also be related to 
physiological aspects of the medical condition (eg, hormone-secreting 
tumors; effects of certain types of medications [bronchodilators]; 
withdrawal from alcohol or narcotics; pain or some other distressing 
physical symptom). Anxiety may not be severe or problematic, but
needs to be addressed when it becomes disruptive. After ruling out 
medical causes, the clinician should assess symptoms to determine the 
particular nature of the anxiety disorder(s). Generalized anxiety 
disorder is usually pre-existing and may be exacerbated by illness. 
Panic disorder may recur during illness in a person with previous panic 
symptoms. Post-traumatic stress disorder may develop after arduous 
cancer treatments or during a cancer treatment that triggers a traumatic 
memory of a past frightening event. Obsessive-compulsive disorder is a 
pre-existing disorder that results in difficulty in making decisions, 
ruminative thoughts about illness, and fearfulness to take medication. 
Some patients develop phobias of needles, hospitals, and blood or 
conditioned nausea/vomiting related to chemotherapy. 
Chemotherapy-induced nausea and vomiting should be managed 
according to the NCCN Guidelines for Antiemesis.
The NCCN Distress Management Panel recommends psychotherapy 
with or without an anxiolytic and/or an antidepressant for the treatment 
of anxiety (category 1), after eliminating medical causes. If the anxiety 
responds to initial treatment, follow-up should occur with the primary 
oncology team and family/caregivers, if no response is noted, the 
patient should be re-evaluated and treated with different medications (a 
neuroleptic should be considered) with continued psychotherapy, 
support, and education. If there is still no response, then the patient 
should be evaluated for depression and other psychiatric comorbidity.
The evidence for the effectiveness of these treatments has been 
reviewed.34,35 In a recent review in The Journal of Clinical Oncology  
Special Series on Psychosocial Care in Cancer, Traeger et al146 give a 
comprehensive description of the evidence for recommended 
pharmacologic and non-pharmacologic treatments for anxiety in 
patients with cancer.
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Substance-Related Disorder/Abuse
Substance abuse is rare among cancer patients who do not have a 
history of active abuse or addiction to opioids, alcohol, or tobacco. 
Substance abuse or dependence developing during the course of the 
treatment may be due to insufficient symptom control and can be 
treated by improving symptom control. In patients with a history of 
substance abuse, its impact on cancer treatment should be assessed. 
After appropriate detoxification regimens, psychoeducation should be 
provided with or without cognitive-behavioral psychotherapy and with or 
without medication. Referral should be made to risk reduction, 
substance abuse management, or specialized treatment programs as 
needed. Patients with a history of substance abuse should be 
monitored for signs and symptoms of relapse.
Personality Disorder
Patients with cancer may have a pre-existing personality disorder, 
which can be exacerbated by the stress of cancer and its treatment.147 
When a personality disorder is suspected, the patient should be 
evaluated by a mental health professional, and safety and decision­
making capacity should be assessed. If possible, any medication or 
other factors that could be aggravating the condition should be 
modified. A coordinated behavioral, psychological, and medical 
treatment plan, with or without medication, should be developed with 
the health care team.
Psychotic Disorder and Schizophrenia
Psychotic disorder includes hallucinations, delusions, and/or thought 
disorders; patients with recurrent psychotic episodes have 
schizophrenia. Psychotic disorder and schizophrenia can exist as 
comorbidities in patients with cancer and can also be caused or 
exacerbated by cancer and its associated stress and treatment. In
particular, steroids or steroid withdrawal can induce psychosis, which 
may be relieved by modifying dose or changing steroid choice.14S’149 
When a patient in a long-term psychiatric facility develops cancer, there 
is a need for coordination of care between the psychiatric facility and 
the inpatient cancer facility Special attention should be paid to the 
transition of a psychiatric patient who needs inpatient oncology care. 
The issues around continuation of psychotropic medications, when they 
must be stopped for surgery or chemotherapy and when they should be 
restarted, are important issues in total care.
When a psychotic episode occurs in a patient with cancer, differential 
diagnoses must be ruled out. Delirium is often confused with psychotic 
disorder and is much more common; dementia, mood disorder, and 
substance abuse/withdrawal should also be considered. When 
psychotic disorder or schizophrenia is diagnosed, several interventions 
can be considered: 1) anti-psychotic medication, 2) medication for 
mood, 3) transfer to a psychiatric unit/hospital, and 4) electroconvulsive 
therapy (ECT) for psychotic depression/mania or catatonia.
In ECT, electrical currents are passed through the brain in a controlled 
fashion, inducing a brief seizure. ECT appears to be an effective 
treatment of psychotic depression, mania, catatonia, and other 
psychiatric disorders.150'154 Although the use of ECT in cancer has not 
been well studied, several case studies suggest that it can be safe and 
effective.155'159
Social Work and Counseling Services
Social work and counseling services are recommended when a patient 
has a psychosocial or practical problem. Practical problems are 
illness-related concerns; concrete needs (eg, housing, food, financial 
assistance, help with activities of daily living, transportation); 
employment, school, or career concerns; cultural or language issues;
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and caregiver availability. The guidelines outline interventions that vary 
according to the severity of the problem.
Psychosocial problems are adjustment to illness; family conflicts and 
social isolation; difficulties in decision making; quality-of-life issues; 
concerns about advance directives; domestic abuse and neglect; poor 
coping or communication skills; concerns about functional changes (eg, 
body image, sexuality); and issues pertaining to end of life and 
bereavement (including cultural and caregiver concerns)
Social workers intervene in mild psychosocial problems by using patient 
and family education, support groups, and/or sex or grief counseling 
and by suggesting available local resources. For moderate to severe 
psychosocial problems, counseling and psychotherapy are used 
(including sex and grief counseling); community resources are 
mobilized; problem solving is taught; and advocacy, education, and 
protective services are made available.
Spiritual Care and Chaplaincy Services
Many patients use their religious and spiritual resources to cope with 
illness160; many cite prayer as a major help. In addition, the diagnosis of 
cancer can cause an existential crisis, making spiritual support of 
critical importance. Balboni et al161 surveyed 230 patients with 
advanced cancer treated at multiple institutions who had failed to 
respond to first-line chemotherapy. The majority of patients (88%) 
considered religion as somewhat or very important. Nearly half of the 
patients (47%) reported receiving very minimal or no support at all from 
their religious community and 72% reported receiving little or no 
support from their medical system.151 Importantly, patients receiving 
spiritual support reported a higher quality of life. Religiousness and 
spiritual support have also been associated with improved satisfaction 
with medical care. Astrow et al162 found that 73% of patients with
cancer had spiritual needs, and that patients whose spiritual needs 
were not met reported lower quality of care and lower satisfaction with 
their care. A recent multi-institution study of 75 patients with cancer and 
339 oncologists and nurses (the Religion and Spirituality in Cancer 
Care Study) found that spiritual care had a positive effect on patient- 
provider relationships and the emotional well-being of patients.163
The panel has included chaplaincy services as part of psychosocial 
services All patients should be referred for chaplaincy services when 
their problems are spiritual or religious in nature or when they request 
it. The panel identified 11 issues related to illness for which people 
often seek chaplaincy services. A treatment guideline is available for 
each of these issues: grief, concerns about death and the afterlife, 
conflicted or challenged belief systems, loss of faith, concerns with 
meaning and purpose of life, concerns about relationship with deity, 
isolation from the religious community, guilt, hopelessness, conflict 
between beliefs and recommended treatments, and ritual needs.
The certified chaplain evaluates the problem and may offer spiritual or 
philosophical reading materials, spiritual advice and guidance, prayer, 
and/or rituals. For patients who are members of a religious community, 
the certified chaplain could also serve as a liaison between the patient 
and the religious community or assist the patient to access spiritual 
resources. Some patients may be referred for social work and 
counseling or mental health services if the problems indicate a need for 
more than spiritual counseling. In addition, patients whose concerns are 
not allayed may be referred for mental health evaluation while 
continuing to receive spiritual counseling if they wish. In particular, 
patients who experience guilt or hopelessness should also be 
evaluated by mental health professionals for further assessment since 
they may also have severe depressive symptoms or suicidal ideations.
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A palliative/supportive care consultation can also be important in 
patients who express hopelessness.
A consensus conference on improving the quality of spiritual care as a 
dimension of palliative care was held in February 2009. The report from 
this conference provides recommendations for health care 
professionals on the integration of spiritual care into the patient’s overall 
treatment plan.164 The inclusion of a certified chaplain in the 
interdisciplinary team is critical for the implementation of spiritual care 
into routine clinical practice.
The following guidelines on religion and spirituality in cancer care may 
be useful for clinicians and patients:
• National Consensus Project Clinical Practice Guidelines for Quality 
Palliative Care, Second Edition, 2009. These guidelines provide a 
framework to acknowledge the patient’s religious and spiritual needs 
in a clinical setting. Spiritual, Religious, and Existential Aspects of 
Care are included as 1 of the 8 clinical practice domains in these 
guidelines: http://www.nationalconsensusproiect.org/auideline.pdf.
• The National Cancer Institute’s comprehensive cancer information 
database (PDQ) has information on “Spirituality in Cancer Care” for 
patients
(http ://www. cancer. qov/cancertopics/pdq/supportivecare/spiritualitv/P 
atierit) and for health care professionals
fhttp ://www.cancer.gov/cancertopios/pda/supportivecare/spiritualitv/H 
ealthProfessionan.
Oncologist Burnout
The stress and demands of treating patients with cancer and making 
life and death decisions daily often cause psychologic distress for 
oncologists. This distress in turn can cause depression, anxiety, and 
fatigue, it can also cause burnout, characterized by a lack of
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enthusiasm for work, feelings of cynicism, and a low sense of personal 
accomplishment with work, in as many as 28% to 38% of oncologists, 
as recently reviewed by Shanafelt and Dyrbye.165 Burnout can affect 
medical care, physician-patient relationships, and personal 
relationships and can lead to substance abuse and even suicide. 
Strategies for avoiding and reducing burnout discussed in the review 
include training in self-care, personal wellness, mindful meditation, and 
behavioral change by medical schools, residency programs, hospitals, 
and private practices. Organizational strategies can also create a 
culture that is less stressful and less conducive of oncologist burnout.
The Journal of Clinical Oncology Special Series on 
Psychosocial Care in Cancer
In April 2012, the Journal o f C linical Oncology published a Special 
Series on psychosocial care fhttp://ico.ascopubs.org/content/30/11 .tocV 
demonstrating that this topic is now getting the attention is has so long 
deserved. The Special Series includes a review by Jacobsen and 
Wagner that describes how the new standard of psychosocial care, the 
development of clinical practice guidelines for psychosocial care such 
as these NCCN guidelines, and the establishment of indicators to 
measure the quality of psychosocial care can help increase the number 
of patients with cancer receiving psychosocial care.166 Integral to the 
successful integration of psychosocial care into routine cancer care is a 
distress screening program. In the Special Series, Carlson et al™ 
present their recommendations for implementing such a program, and 
Fann et al51 discuss the organizational challenges of this new integrated 
care model, with a focus on the collaborative care service model,
Research on psychosocial care in cancer treatment has expanded 
greatly in recent years. This fact attests to the growing awareness of 
the importance of the topic, both by health care professionals and by 
the public.167 The Special Series includes reviews of evidence-based
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interventions for 3 common psychosocial problems in patients with 
cancer: depression, anxiety, and delirium.136,144’146
Worries and concerns about cancer do not necessarily end with the end 
of acute care. The Special Series thus also includes articles addressing 
the psychosocial needs of adolescent and young adult (AYA) and adult 
cancer survivors.168,169 An article on the psychosocial needs of care 
givers is also included.170
In addition, an article was included on ‘oncologist burnout,' a problem 
with an estimated prevalence of 28% to 38%, depending on medical 
specialty.165 The Special Series concludes with a review and meta­
analysis of studies that provide evidence for the development of an 
appropriate curriculum for communication skills training of oncologists.,9 
Patient benefit from such training (ex, better adherence to treatment) 
has yet to be demonstrated.
Summary
Psychosocial care is increasingly being recognized as an integral 
component of the clinical management of cancer patients. Treating 
distress in cancer benefits the patients and their families/caregiver as 
well as the treating staff and helps improve the efficiency of clinic 
operations. For patients with cancer, integration of mental health and 
medical services is critically important. Spirituality and religion also play 
an important role for many patients with cancer in coping with the 
diagnosis and the illness.
The NCCN Guidelines for Distress Management recommend that each 
new patient be rapidly assessed in the off ce or clinic waiting room for 
evidence of distress using the Distress Thermometer and Problem List 
as an initial rough screen.171 A score of 4 or greater on the DT should 
trigger further evaluation by the oncologist or nurse and referral to a
psychosocial service, if needed. The choice of which psychological 
service is needed is dependent on the problem areas specified on the 
Problem List. Patients with practical and psychosocial problems should 
be referred to social workers; those with emotional or psychological 
problems should be referred to mental health professionals including 
social workers; spiritual concerns should be referred to certified 
chaplains.
Health care contracts often allow these services to “fall through the 
cracks” by failing to reimburse for them through either behavioral health 
or medical insurance. Reimbursement for services to treat psychosocial 
distress must be included in medical health care contracts to prevent 
fragmentation of mental health services for the medically ill. Outcomes 
research studies that include quality-of-life assessment and analysis of 
cost-effectiveness are needed to help make this a reality.
The primary oncology team members (oncologist, nurse, and social 
worker) are central to making this model work. It is critical for at least 
one team member to be familiar with the mental health, psychosocial, 
and chaplaincy services available in the institution and the community. 
A list of the names and phone numbers for these resources should be 
kept in all oncology clinics and should be updated frequently.
Education of patients and families is equally important to encourage 
them to recognize that control of distress is an integral part of their total 
cancer care.
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form without the express written permission o f NCCN®.MS -17
119
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
References
1. Siegel R, Naishadharrt D, Jemal A. Cancer statistics, 2012. CA 
Cancer J Clin 2012;62:10-29. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22237781.
2. Carr D, Goudas L, Lawrence D, et al. Management of Cancer 
Symptoms: Pain, Depression, and Fatigue. Evidence 
Report/Technology Assessment No. 61 (Prepared by the New England 
Medical Center Evidence-based Practice Center under Contract No 
290-97-0019). AHRQ Publication No. 02-E032, Rockville, MD: Agency 
for Healthcare Research and Quality; 2002. Available at: 
http://archive.ahra.aov/downloads/pub/evidence/pdf/cansvmp/cansvmp. 
jX[f.
3. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of 
cancer and cancer treatment due to a shared biologic mechanism? A 
cytokine-immunologic model of cancer symptoms. Cancer 
2003;97:2919-2925. Available at: ' 
http://www.ncbi.nlm.nih.gov/pubmed/12767108.
4. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to 
sickness and depression: when the immune system subjugates the 
brain. Nat Rev Neurosci 2008;9:46-56. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/18073775.
5. Miller K, Massie MJ. Depression and anxiety. Cancer J 2006; 12:388­
397. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17034675.
6. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the 
immune system, and cancer. Lancet Oncol 2004;5:617-625. Available 
at: http://www.ncbi.nlm.nih.qov/pubmed/15465465.
7. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of 
psychological distress by cancer site. Psychooncology 2001;10:19-28. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/11180574.
8. Carlsen K, Jensen AB, Jacobsen E, et al. Psychosocial aspects of 
lung cancer. Lung Cancer 2005;47:293-300. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15713512.
9. Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of 
psychiatric disorders among cancer patients. JAMA 1983;249:751-757. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/6823028.
10. Hegel MT, Moore CP, Collins ED, etal. Distress, psychiatric 
syndromes, and impairment of function in women with newly diagnosed 
breast cancer. Cancer 2006;107:2924-2931. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17103381.
11. Spiegel D, Giese-Davis J. Depression and cancer; mechanisms and 
disease progression. Biol Psychiatry 2003;54:269-282. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12893103.
12. Holland JC, Alici Y. Management of distress in cancer patients. J 
Support Oncol 2010;8:4-12. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20235417.
13. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and 
depression after cancer diagnosis; Prevalence rates by cancer type, 
gender, and age. J Affect Disord 2012. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22727334.
14. Massie MJ. Prevalence of Depression in Patients With Cancer. J 
Natl Cancer Inst Monogr 2004:57-71. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/15263042.
15. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, 
anxiety, and adjustment disorder in oncological, haematological, and 
palliative-care settings: a meta-analysis of 94 interview-based studies. 
Lancet Oncol 2011;12:160-174. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21251875.
16. Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to 
adjuvant tamoxifen therapy in women with primary breast cancer. J Clin
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form without the express written permission o f NCCN®.MS -18
120
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
Oncol 2003;21:602-606. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/12586795.
17. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor 
for noncompliance with medical treatment: meta-analysis of the effects 
of anxiety and depression on patient adherence. Arch Intern Med 
2000:160:2101-2107. Available at: 
http://www.ncbi.nlm.nih.gov/i3ubmed/10904452.
18. Bultz BD, Holland JC. Emotional distress in patients with cancer: 
the sixth vital sign. Commun Oncol 2006;3:311-314. Available at:
http://www.communitvoncoloav.net/co/ioumal/articles/0305311 pdf.
19. Carlson LE, Bultz BD. Efficacy and medical cost offset of 
psychosocial interventions in cancer care: making the case for 
economic analyses. Psychooncology 2004;13:837-849; discussion 850­
836. Available at: http://wvwv.ncbi.nlm.nih.gov/pubmed/15578622.
20. Brown KW, LevyAR, RosbergerZ, Edgar L. Psychological distress 
and cancer survival: a follow-up 10 years after diagnosis. Psychosom 
Med 2003;65:636-643. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12883115.
21. Kissane D. Beyond the psychotherapy and survival debate: the 
challenge of social disparity, depression and treatment adherence in 
psychosocial cancer care. Psychooncology 2009;18:1-5. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19097139.
22. Carmack CL, Basen-Engquist K, Gritz ER. Survivors at higher risk 
for adverse late outcomes due to psychosocial and behavioral risk 
factors. Cancer Epidemiol Biomarkers Prev 2011;20:2068-2077. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/21980014.
23. Carlson LE, Bultz BD. Cancer distress screening. Needs, models, 
and methods. J Psychosom Res 2003;55:403-409. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/14581094.
24. Zabora JR. Screening procedures for psychosocial distress. In: 
Holland JC, Breitbart W, Jacobsen PB, al. e, eds. Psycho oncology. 
New York, NY: Oxford University Press; 1998:653-661.
25. Carlson LE, Groff SL, Maciejewski O, Bultz BD. Screening for 
distress in lung and breast cancer outpatients: a randomized controlled 
trial. J Clin Oncol 2010;28:4884-4891. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20940193.
26. Spiegel D. Mind matters in cancer survival. Psychooncology 
2012;21:588-593. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22438289.
27. Kadan-Lottick NS, Vanderwerker LC, Block SD, et al. Psychiatric 
disorders and mental health service use in patients with advanced 
cancer: a report from the coping with cancer study. Cancer 
2005;104:2872-2881. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16284994.
28. Sharpe M, Strong V, Allen K, et al. Major depression in outpatients 
attending a regional cancer centre: screening and unmet treatment 
needs. Br J Cancer 2004;90:314-320. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/14735170.
29. Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity 
and its recognition by doctors in patients with cancer. Br J Cancer 
2001;84:1011-1015. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/11308246.
30. Holland JC. American Cancer Society Award lecture. Psychological 
care of patients: psycho-oncology's contribution. J Clin Oncol
2003;21:253s-265s. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/14645405.
31. Fitchett G, Handzo G. Spiritual assessment, screening, and 
intervention. In: Holland JC, ed. Psycho Oncology. New York: Oxford 
University Press; 1998:790-808.
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form without the express written permission o f NCCN®.MS -19
121
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
32. Holland JC, Greenberg DB, Hughes MK. Quick Reference for 
Oncology Clinicians: The Psychiatric and Psychological Dimensions of 
Cancer Symptom Management Oncology IPOS press; 2006.
33. Holland JC, Andersen B, Breitbart WS, et al. Distress management. 
J Natl Compr Cane Netw 2010;8:448-485. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20410337.
34. Adler NE, Page NEK. Institute of Medicine (IOM). 2008. Cancer 
Care for the Whole Patient: Meeting Psychosocial Health Needs. 2008. 
Available at: http://www.iom.edu/Reports/2007/Cancer-Care-for-the- 
Whole-Patient-Meeting-Psvchosocial-Health-Needs.aspx.
35. Jacobsen PB, Jim HS, Psychosocial interventions for anxiety and 
depression in adult cancer patients: achievements and challenges. CA 
Cancer J Clin 2008;58:214-230. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18558664.
36. Bultz BD, Carlson LE. Emotional distress: the sixth vital sign in 
cancer care. J Clin Oncol 2005;23:6440-6441. Available at:
http://www.ncbi.nlm.nih.aov/pubmed/16155033.
37. Quality improvement guidelines for the treatment of acute pain and 
cancer pain. American Pain Society Quality of Care Committee. JAMA 
1995;274:1874-1880. Available at: 
http://www.ncbi.nlm.nih.aov/pubmed/7500539.
38. Jacobsen PB, Ransom S. Implementation of NCCN distress 
management guidelines by member institutions. J Natl Compr Cane 
Netw 2007;5:99-103, Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17239329.
39. Jacobsen PB. Promoting evidence-based psychosocial care for 
cancer patients. Psychooncology 2009;18:6-13. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/19097140.
40. Neuss MN, Desch CE, McNiff KK, et al. A Process for Measuring 
the Quality of Cancer Care: The Quality Oncology Practice Initiative. J
Clin Oncol 2005;23:6233-6239. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16087948.
41. Jacobson JO, Neuss MN, McNiff KK, etal. Improvement in 
Oncology Practice Performance Through Voluntary Participation in the 
Quality Oncology Practice Initiative. J Clin Oncol 2008;26:1893-1898. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/18398155.
42. Blayney DW, McNiff K, Hanauer D, et al. Implementation of the 
Quality Oncology Practice Initiative at a University Comprehensive 
Cancer Center. J Clin Oncol 2009;27:3802-3807, Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/19487377.
43. Jacobsen PB. Improving psychosocial care in outpatient oncology 
settings. J Natl Compr Cane Netw 2010;8:368-370. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20410332.
44. Rodriguez MA, Tortorella F, St John C. Improving psychosocial 
care for improved health outcomes. J Healthc Qua! 2010;32:3-12. 
Available at: http://www.ncbi.nlm.nih.aov/pubmed/20618566.
45. Frost GW, Zevon MA, Gruber M, Scrivani RA. Use of distress 
thermometers in an outpatient oncology setting. Health Soc Work 
2011;36:293-297. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22308881.
46. Fulcher CD, Gosselin-Acomb TK. Distress assessment: practice 
change through guideline implementation. Clin J Oncol Nurs 
2007;11:817-821. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18063540.
47. Hendrick SS, Cobos E. Practical model for psychosocial care. J 
Oncol Pract 2010;6:34-36. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20539730.
48. Loscalzo M, Clark KL, Holland J. Successful strategies for 
implementing biopsychosocial screening. Psychooncology
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form  w ithou t the express w ritten  perm ission o f  NCCN®.M S  - 2 0
122
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
2011;20:455-462. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21456059.
49. Mehta A, Hamel M. The development and impact of a new 
Psychosocial Oncology Program. Support Care Cancer2011;19:1873- 
1877. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21681386.
50. Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet 
needs in patients with cancer: review and recommendations. J Clin 
Oncol 2012;30:1160-1177. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22412146.
51. Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer 
services, J Clin Oncol 2012;30:1178-1186. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22412139.
52. Lowery AE, Holland JC. Screening cancer patients for 
distress:guidelines for routine implementation. Community Oncology 
2011;8:502-505. Available at: " 
http://www.communitvoncoloav.net/fileadmin/content imaaes/co/article 
s/0811502.pdf.
53. Bultz BD, Groff SL, Fitch M, etal. Implementing screening for 
distress, the 6th vital sign: a Canadian strategy for changing practice. 
Psychooncology 2011 ;20:463-469. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21456060.
54. Dolbeault S, Boistard B, Meuric J, et al. Screening for distress and 
supportive care needs during the initial phase of the care process: a 
qualitative description of a clinical pilot experiment in a French cancer 
center. Psychooncology 2011 ;20:585-593. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21425386.
55. Grassi L, Rossi E, Caruso R, et al. Educational intervention in 
cancer outpatient clinics on routine screening for emotional distress: an 
observational study. Psychooncology 2011 ;20:669-674. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21370316.
56. Mitchell AJ. Pooled results from 38 analyses of the accuracy of 
distress thermometer and other ultra-short methods of detecting 
cancer-related mood disorders. J Clin Oncol 2007;25:4670-4681. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/17846453.
57. Zabora J, BrintzenhofeSzoc K, Jacobsen P, et al. A new 
psychosocial screening instrument for use with cancer patients. 
Psychosomatics 2001;42:241-246. Available at:
http://www.ncbi.nlm.nih.gOv/pubmed/11351113.
58. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. 
Acta Psychiatr Scand 1983;67:361-370. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/6880820.
59. Mitchell AJ, Kaar S, Coggan C, Herdman J. Acceptability of 
common screening methods used to detect distress and related mood 
disorders-preferences of cancer specialists and non-specialists. 
Psychooncology 2008;17:226-236. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17575565.
60. Mitchell AJ. Short Screening Tools for Cancer-Related Distress: A 
Review and Diagnostic Validity Meta-Analysis. Journal of the National 
Comprehensive Cancer Network 2010;8:487-494. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20410338.
61. Carlson LE, Waller A, Groff SL, et al. Online screening for distress, 
the 6th vital sign, in newly diagnosed oncology outpatients: randomised 
controlled trial of computerised vs personalised triage, Br J Cancer 
2012;107:617-625. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22828610.
62. Loscalzo M, Clark K, Dillehunt J, et al. SupportScreen: A Model for 
Improving Patient Outcomes. Journal of the National Comprehensive 
Cancer Network 2010;8:496-504. Available at: 
http://www.inccn.Org/contert/8/4/496.abstract.
63. Miller MF, Buzaglo JS, Clark KL, et al. Demonstrating the 
psychometric properties of a problem-related distress screener in a
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form without the express written permission o f NCCN®.MS -21
123
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
community sample of 319 cancer survivors. Psychooncology 2012. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/22736627.
64. Mitchell AJ, Meader N, Davies E, et al. Meta-analysis of screening 
and case finding tools for depression in cancer: evidence based 
recommendations for clinical practice on behalf of the Depression in 
Cancer Care consensus group. J Affect Disord 2012;140:149-160. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/22633127.
65. Akizuki N, Akechi T, Nakanishi T, et al. Development of a brief 
screening interview for adjustment disorders and major depression in 
patients with cancer. Cancer 2003;97:2605-2613. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12733160.
66. Dabrowski M, Boucher K, Ward JH, et al. Clinical experience with 
the NCCN distress thermometer in breast cancer patients. J Natl 
Compr Cane Netw 2007;5:104-111. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17239330.
67. Hoffman BM, Zevon MA, D'Arrigo MC, Cecchini TB. Screening for 
distress in cancer patients: the NCCN rapid-screening measure. 
Psychooncology 2004;13:792-799. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/15386639.
68. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for 
psychologic distress in ambulatory cancer patients. Cancer 
2005;103:1494-1502. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15726544.
69. Patrick-Miller LJ, Broccoli TL, Much JK, Levine E. Validation of the 
Distress Thermometer: A single item screen to detect clinically 
significant psychological distress in ambulatory oncology patients 
[abstract]. J Clin Oncol 2004;22 (Suppl_14):6024. Available at:
http://meetina.ico.ora/cgi/content/abstract/22/14 suppl/6024.
70. Roth AJ, Kornblith AB, Batel-Copel L, et al. Rapid screening for 
psychologic distress in men with prostate carcinoma: a pilot study.
Cancer 1998;82:1904-1908. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9587123.
71. Zwahlen D, Hagenbuch N, Carley Ml, etal. Screening cancer 
patients' families with the distress thermometer (DT): a validation study. 
Psychooncology 2008;17:959-966. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/18203146.
72. Graves KD, Arnold SM, Love CL, et al. Distress screening in a 
multidisciplinary lung cancer clinic: prevalence and predictors of 
clinically significant distress. Lung Cancer 2007;55:215-224. Available
at: http://www.ncbi.nlm.nih.gov/pubmed/17084483.
73. Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. 
Screening and referral for psychosocial distress in oncologic practice: 
use of the Distress Thermometer. Cancer 2008;113:870-878. Available
at: http://www.ncbi.nlm.nih.gov/pubmed/18618581.
74. Ransom S, Jacobsen PB, Booth-Jones M. Validation of the Distress 
Thermometer with bone marrow transplant patients. Psychooncology 
2006;15:604-612. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16208733.
75. Trask PC, Paterson A, Riba M, et al. Assessment of psychological 
distress in prospective bone marrow transplant patients. Bone Marrow 
Transplant 2002;29:917-925. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/12080358.
76. Janelsins MC, Kohli S, Mohile SG, et al. An update on cancer- and 
chemotherapy-related cognitive dysfunction: current status, Semin 
Oncol 2011 ;38:431-438. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/216Q0374.
77. Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition 
and Cancer Task Force recommendations to harmonise studies of 
cognitive function in patients with cancer. Lancet Oncol 2011 ;12:703- 
708. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21354373.
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form  w ithou t the express w ritten  perm ission o f  NCCN®.M S  - 2 2
124
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
78. Anderson-Hanley C, Sherman ML, Riggs R, et al. 
Neuropsychological effects of treatments for adults with cancer: A 
meta-analysis and review of the literature. Journal of the International 
Neuropsychological Society 2003;9:967-982. Available at: 
http://www.ncbi.nlm.nih.aov/pubmed/14738279.
79. Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of 
chemotherapy-induced structural changes in cerebral white matter and 
its correlation with impaired cognitive functioning. J Clin Oncol
2012;30:274-281. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22184379.
80. Stewart A, Bielajew C, Collins B, et al. A meta-analysis of the 
neuropsychological effects of adjuvant chemotherapy treatment in 
women treated for breast cancer. Clin Neuropsychol 2006;20:76-89. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/16410227.
81.VardyJ, Rourke S, Tannock IF. Evaluation of cognitive function 
associated with chemotherapy: a review of published studies and 
recommendations for future research. J Clin Oncol 2007;25:2455-2463. 
Available at: http://www.ncbi.nlm.nih.aov/pubmed/17485710.
82. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy- 
induced cognitive changes. Nat Rev Cancer 2007;7:192-201. Available
at: http://www.ncbi.nlm.nih.aov/pubmed/17318212.
83. Ahles TA, Saykin AJ, McDonald BC, et al, Cognitive function in 
breast cancer patients prior to adjuvant treatment. Breast Cancer Res 
Treat 2008;110:143-152. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17674194.
84. Ahles TA, Saykin AJ, McDonald BC, et al. Longitudinal assessment 
of cognitive changes associated with adjuvant treatment for breast 
cancer: impact of age and cognitive reserve. J Clin Oncol 
2010;28:4434-4440. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20837957.
85. Wefel JS, Lenzi R, Theriault R, et al. 'Chemobrain' in breast 
carcinoma?: a prologue. Cancer 2004;101:466-475. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15274059.
86. Wefel JS, Lenzi R, Theriault RL, et al. The cognitive sequelae of 
standard-dose adjuvant chemotherapy in women with breast 
carcinoma: results of a prospective, randomized, longitudinal trial. 
Cancer 2004;100:2292-2299. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/15160331.
87. Jean-Pierre P, Winters PC, Ahles TA, et al. Prevalence of self­
reported memory problems in aduit cancer survivors: a national cross- 
sectionai study. J Oncol Pract 2012;8:30-34. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22548008.
88. Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive 
deficits: mechanisms, findings, and potential interventions. Palliat 
Support Care 2007;5:273-280. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17969831.
89. Ferguson RJ, McDonald BC, Rocque MA, etal. Development of 
CBT for chemotherapy-related cognitive change: results of a waitlist 
control trial. Psychooncology 2012;21:176-186. Available at:
http://www.ncbi.nlm.nih.aov/pubmed/22271538.
90. Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies 
on interventions for cognitive deficits in patients with cancer. Expert 
Rev Anticancer Ther 2012; 12:255-269. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22316373.
91. Kohli S, Fisher SG, Tra Y, et al. The effect of modafinil on cognitive 
function in breast cancer survivors. Cancer 2009; 115:2605-2616. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/19309747.
92. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate 
therapy improves cognition, mood, and function of brain tumor patients. 
J Clin Oncol 1998;16:2522-2527. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9667273.
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form  w ithou t the express w ritten  perm ission o f  N C C N ® .M S  - 2 3
125
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ationa l
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
93. Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients 
with cancer. Am J Hosp PalliatCare 2006;23:35-40. Available at: 
http://www.ncbi.nlm.nih.aov/pubmed/16450661.
94. Shaw EG, Rosdhai R, D'Agostino RB, Jr., et al. Phase II study of 
donepezil in irradiated brain tumor patients: effect on cognitive function, 
mood, and quality of life. J Clin Oncol 2006;24:1415-1420. Available at:
http://www.ncbi.nlm.nih.gov/i3ubmed/16549835.
95. Vardy J, Wefel JS, Ahles T, et al. Cancer and cancer-therapy 
related cognitive dysfunction: an international perspective from the 
Venice cognitive workshop. Ann Oncol 2008;19:623-629. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17974553.
96. Lee SJ, Schover LR, Partridge AH, et al. American Society of 
Clinical Oncology recommendations on fertility preservation in cancer 
patients. J Clin Oncol 2006;24:2917-2931. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16651642.
97. Back AL, Arnold RM, Baile WF, et al. Approaching difficult 
communication tasks in oncology. CA Cancer J Clin 2005;55:164-177. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/15890639.
98. Ryan H, Schofield P, Cockburn J, et al. Howto recognize and 
manage psychological distress in cancer patients. Eur J Cancer Care 
(Engl) 2005;14:7-15. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/15698382.
99. Kissane DW, Bylund CL, Banerjee SC, et al. Communication skills 
training for oncology professionals. J Clin Oncol 2012;30:1242-1247. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/22412145.
100. Komblith AB, Dowell JM, Herndon JE, 2nd, et al. Telephone 
monitoring of distress in patients aged 65 years or older with advanced 
stage cancer: a cancer and leukemia group B study. Cancer 
2006;107:2706-2714. Available at: ' 
http://www.ncbi.nlm.nih.gov/pubmed/17078057.
101. Greer JA, Traeger L, Bemis H, et al. A Pilot Randomized 
Controlled Trial of Brief Cognitive-Behavioral Therapy for Anxiety in 
Patients with Terminal Cancer. Oncologist 2012. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22688670.
102. Moorey S, Greer S, Bliss J, Law M. A comparison of adjuvant 
psychological therapy and supportive counselling in patients with 
cancer, Psychooncology 1998;7:218-228, Available at:
http://www.ncbi.nlm.nih.gov/pubmed/9638783.
103. Gielissen MF, Verhagen CA, Bleijenberg G. Cognitive behaviour 
therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer 
2007;97:612-618. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17653075.
104. Campbell CL, Campbell LC. A systematic review of cognitive 
behavioral interventions in advanced cancer. Patient Educ Couns 2012, 
Available at: http://www.ncbi.nlm.nih.aov/pubmed/22796302.
105. Ferguson RJ, Ahles TA, Saykin AJ, et al. Cognitive-behavioral 
management of chemotherapy-related cognitive change. 
Psychooncology 2007;16:772-777. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17152119.
106. Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group 
psychosocial support on survival in metastatic breast cancer. N Engl J 
Med 2001 ;345:1719-1726, Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/11742045.
107. Kissane DW, Grabsch B, Clarke DM, etal. Supportive-expressive 
group therapy for women with metastatic breast cancer: survival and 
psychosocial outcome from a randomized controlled trial. 
Psychooncology 2007;16:277-286. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17385190.
108. Kissane DW, Bloch S, Smith GC, et al. Cognitive-existential group 
psychotherapy for women with primary breast cancer: a randomised
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form without the express written permission o f NCCN®.M S - 2 4
126
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
controlled trial. Psychooncology 2003;12:532-546. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/12923794.
109. Breitbart W, Rosenfeld B, Gibson C, et al. Meaning-centered 
group psychotherapy for patients with advanced cancer: a pilot 
randomized controlled trial. Psycho-Oncology 2010;19:21-28. Available
at: http://www.ncbi.nlm.nih.gov/pubmed/19274623.
110. Breitbart W, PoppitoS, Rosenfeld B, etal. Pilot Randomized 
Controlled Trial of Individual Meaning-Centered Psychotherapy for 
Patients With Advanced Cancer. J Clin Oncol 2012, Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22370330.
111. Chochinov HM, Kristjanson LJ, Breitbart W, et al, Effect of dignity 
therapy on distress and end-of-life experience in terminally ill patients: a 
randomised controlled trial. Lancet Oncol 2011;12:753-762. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/21741309.
112. Manne SL, Ostroff JS, Norton TR, et al. Cancer-related 
relationship communication in couples coping with early stage breast 
cancer. Psychooncology 2006;15:234-247. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15926198.
113. McLean LM, Walton T, Rodin G, et al. A couple-based intervention 
for patients and caregivers facing end-stage cancer: outcomes of a 
randomized controlled trial. Psychooncology 2011. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21919119.
114. Kissane DW, McKenzie M, Bloch S, et al. Family focused grief 
therapy: a randomized, controlled trial in palliative care and 
bereavement. Am J Psychiatry 2006;163:1208-1218. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16816226.
115. Regan TW, Lambert SD, Girgis A, et al. Do couple-based 
interventions make a difference for couples affected by cancer?: a 
systematic review. BMC Cancer 2012;12:279 Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22769228.
116. Jacobsen PB, Donovan KA, Swaine ZN, Watson IS. Management 
of Anxiety and Depression in Adult Cancer Patients: Toward an 
Evidence-Based Approach. In: Chang AE, Hayes DF, Pass HI, et a!., 
eds. Oncology: Springer New York; 2006:1561-1588.
117. Ng CG, Boks MP, Zainal NZ, de Wit NJ. The prevalence and 
pharmacotherapy of depression in cancer patients. J Affect Disord 
2011;131:1-7. Available at: '
http://www.ncbi.nlm.nih.gov/pubmed/20732716.
118. Pirl WF. Evidence report on the occurrence, assessment, and 
treatment of depression in cancer patients. J Natl Cancer Inst Monogr 
2004:32-39. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15263039.
119. Rayner L, Price A, Evans A, et al. Antidepressants for depression 
in physically ill people. Cochrane Database Syst Rev 
2010;3:CD007503. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20238354.
120. Rayner L, Price A, Evans A, et al. Antidepressants for the 
treatment of depression in palliative care: systematic review and meta­
analysis. Palliat Med 2010;25:36-51. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20935027.
121. Rodin G, Katz M, Lloyd N, et al. Treatment of depression in cancer 
patients, Curr Oncol 2007;14:180-188. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17938701.
122. Williams S, Dale J. The effectiveness of treatment for 
depression/depressive symptoms in adults with cancer: a systematic 
review. Br J Cancer 2006;94:372-390. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16465173.
123. Holland JC, Morrow GR, Schmale A, et al. A randomized clinical 
trial of alprazolam versus progressive muscle relaxation in cancer 
patients with anxiety and depressive symptoms. J Clin Oncol
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form  w ithou t the express w ritten  perm ission o f  N C C N ® .M S  - 2 5
127
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
1991;9:1004-1011. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/2033413.
124. Wald TG, Kathol RG, Noyes R, Jr., et al. Rapid relief of anxiety in 
cancer patients with both alprazolam and placebo. Psychosomatics 
1993;34:324-332. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/8351307.
125. Fisch MJ, Loehrer PJ, Kristeller J, et al. Fluoxetine versus placebo 
in advanced cancer outpatients: a double-blinded trial of the Hoosier 
Oncology Group. J Clin Oncol 2003;21:1937-1943. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12743146.
126. Holland JC, Romano SJ, Heiligenstein JH, et al. A controlled trial 
of fluoxetine and desipramine in depressed women with advanced 
cancer. Psychooncology 1998;7:291-300. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9741068.
127. Breitbart W, Alici Y. Psychostimulants for cancer-related fatigue. J 
Natl Compr Cane Netw 2010;8:933-942. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20870637.
128. Minton O, Richardson A, Sharpe M, et al. Drug therapy for the 
management of cancer-related fatigue. Cochrane Database Syst Rev 
2010:CD006704. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20614448.
129. Minton O, Richardson A, Sharpe M, et al. Psychostimulants for the 
management of cancer-related fatigue: a systematic review and meta­
analysis. J Pain Symptom Manage 2011;41:761-767. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21251796.
130. Howard LM, Barley EA, Davies E, et al. Cancer diagnosis in 
people with severe mental illness: practical and ethical issues. Lancet 
Oncol 2010;11:797-804. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20599423.
131. Legler A, Bradley EH, Carlson MD. The effect of comorbidity 
burden on health care utilization for patients with cancer using hospice. 
J Palliat Med 2011 ;14:751-756. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21548813.
132. Raji MA, Kuo YF, Freeman JL, Goodwin JS. Effect of a dementia 
diagnosis on survival of older patients after a diagnosis of breast, colon, 
or prostate cancer: implications for cancer care. Arch Intern Med 
2008;168:2033-2040. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/18852406.
133. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and 
outcome of delirium in patients with advanced cancer: a prospective 
study. Arch Intern Med 2000;160:786-794. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/10737278.
134. Dy SM, Apostol CC. Evidence-based approaches to other 
symptoms in advanced cancer. Cancer J 2010;16:507-513, Available
at: http://www.ncbi.nlm.nih.gov/pubmed/20890148.
135. Young J, Murthy L, Westby M, et al. Diagnosis, prevention, and 
management of delirium: summary of NICE guidance. BMJ
2010;341 :c3704. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20667955.
136. Breitbart W, Alici Y. Evidence-based treatment of delirium in 
patients with cancer. J Clin Oncol 2012;30:1206-1214, Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22412123.
137. Miller M, Mogun H, Azrael D, et al. Cancer and the risk of suicide 
in older Americans. J Clin Oncol 2008;26:4720-4724. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18695256.
138. Misono S, Weiss NS, Fann JR, et al. Incidence of suicide in 
persons with cancer. J Clin Oncol 2008;26:4731-4738. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18695257.
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form  w ithou t the express w ritten  perm ission o f  N C C N ® .M S  - 2 6
128
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
139. Walker J, Waters RA, Murray G, et al. Better off dead: suicidal 
thoughts in cancer patients. J Clin Oncol 2008;26:4725-4730. Available
at: http://www.ncbi.nlm.nih.aov/pubmed/18695258.
140. Kendal W. Suicide and cancer: a gender-comparative study. 
Annals of Oncology 2007;18:381-387. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17053045.
141. DySM, Lorenz KA, Naeim A, et al. Evidence-based 
recommendations for cancer fatigue, anorexia, depression, and 
dyspnea. J Clin Oncol 2008;26:3886-3895. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/18688057.
142. Hart SL, Hoyt MA, Diefenbach M, et al. Meta-analysis of efficacy 
of interventions for elevated depressive symptoms in adults diagnosed 
with cancer. J Natl Cancer Inst 2012;104:990-1004. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22767203.
143. Piet J, Wurtzen H, Zachariae R. The Effect of Mindfulness-Based 
Therapy on Symptoms of Anxiety and Depression in Adult Cancer 
Patients and Survivors: A Systematic Review and Meta-Analysis. J 
Consult Clin Psychol 2012. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22563637.
144. Li M, Fitzgerald P, Rodin G. Evidence-based treatment of 
depression in patients with cancer. J Clin Oncol 2012;30:1187-1196. 
Available at: http://www.ncbi.nlm.nih.aov/pubmed/22412144.
145. Stark D, Kiely M, Smith A, et al. Anxiety disorders in cancer 
patients: their nature, associations, and relation to quality of life. J Clin 
Oncol 2002;20:3137-3148. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12118028.
146. Traeger L, Greer JA, Fernandez-Robles C, et al. Evidence-based 
treatment of anxiety in patients with cancer. J Clin Oncol 2012;30:1197- 
1205. Available at: http://www.ncbi.nim.nih.aov/pubmed/22412135.
147. Meyer F, Block S. Personality disorders in the oncology setting. J 
Support Oncol 2011 ;9:44-51. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21542408.
148. Kenna HA, Poon AW, de !os Angeles CP, Koran LM. Psychiatric 
complications of treatment with corticosteroids: review with case report. 
Psychiatry Clin Neurosci 2011;65:549-560. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/220Q3987.
149. Sirois F. Steroid psychosis: a review. Gen Hosp Psychiatry 
2003;25:27-33. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12583925.
150. Fink M. Convulsive therapy in delusional disorders, PsychiatrClin 
North Am 1995;18:393-406. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/7659606.
151. Gazdag G, Ungvari GS. Non-pharmacological biological therapies 
in schizophrenia. Neuropsychopharmacol Hung 2011;13:233-238. 
Available at: http://www.ncbi.nlm.nih.aov/pubmed/22184192.
152. Greenhalgh J, Knight C, Hind D, et al. Clinical and cost- 
effectiveness of electroconvulsive therapy for depressive illness, 
schizophrenia, catatonia and mania: systematic reviews and economic 
modelling studies. Health Technol Assess 2005;9:1-156, iii-iv. Available 
at: http://www.ncbi.nlm.nih.aov/pubmed/15774232.
153. Tharyan P, Adams CE. Electroconvulsive therapy for 
schizophrenia. Cochrane Database Syst Rev 2005:CD000076. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/15846598.
154. Zervas IM, Theleritis C, Soldatos CR. Using ECT in schizophrenia: 
a review from a clinical perspective. World J Biol Psychiatry 
2012;13:96-105. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21486108.
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form  w ithou t the express w ritten  perm ission o f  N C C N ® .M S  - 2 7
129
Priired by Denise Sartz on 11/26/2012 6:19:51 PM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN
N ational
C om prehensive NCCN Guidelines Version 2.2013 
Network® Distress Management
NCCN Guidelines Index 
Distress Management Table of Contents
Discussion
155. Beale MD, Kellner CH, Parsons PJ. ECT for the treatment of mood 
disorders in cancer patients. Convuls Ther 1997;13:222-226. Available 
at: http://www.ncbi.nlm.nih.aov/pubmed/9437566.
156. Kaestner F, Mostert C, Behnken A, et al. Therapeutic strategies 
for catatonia in paraneoplastic encephalitis. World J Biol Psychiatry 
2008;9:236-240. Available at: ' '
http://www.ncbi.nlm.nih.gov/i3ubmed/17853266.
157. Kohler CG, Burock M. ECT for psychotic depression associated 
with a brain tumor. Am J Psychiatry 2001; 158:2089. Available at: 
http://www.ncbi.nlm.nih.goV/pubmed/11729041.
158. McKinney PA, Beale MD, Kellner CH. Electroconvulsive therapy in 
a patient with a cerebellar meningioma. J ECT 1998;14:49-52.
Available at: http://www.ncbi.nlm.nih.gov/pubmed/9661094.
159. Sutor B, Wells LA, Rummans TA. Steroid-induced depressive 
psychosis responsive to electroconvulsive therapy. Convuls Ther 
1996;12:104-107. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/8744170.
160. Vallurupalli M, Lauderdale K, Balboni MJ, etal. The role of 
spirituality and religious coping in the quality of life of patients with 
advanced cancer receiving palliative radiation therapy. J Support Oncol 
2012;10:81-87. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22088828.
161. Balboni TA, Vanderwerker LC, Block SD, et al. Religiousness and 
Spiritual Support Among Advanced Cancer Patients and Associations 
With End-of-Life Treatment Preferences and Quality of Life. J Clin 
Oncol 2007;25:555-560. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17290065.
162. Astrow AB, Wexler A, Texeira K, et al. Is failure to meet spiritual 
needs associated with cancer patients' perceptions of quality of care 
and their satisfaction with care? J Clin Onool 2007;25:5753-5757. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/18089871.
163. Phelps AC, Lauderdale KE, Alcorn S, et al. Addressing spirituality 
within the care of patients at the end of life: perspectives of patients 
with advanced cancer, oncologists, and oncology nurses. J Clin Oncol 
2012;30:2538-2544. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22614979.
164. Puchalski C, Ferrell B, Virani R, et al. Improving the Quality of 
Spiritual Care as a Dimension of Palliative Care: The Report of the 
Consensus Conference. Journal of Palliative Medicine 2009;12:885- 
904. Available at: http://www.ncbi.nlm.nih.aov/pubmed/19807235.
165. Shanafelt T, Dyrbye L. Oncologist burnout: causes, 
consequences, and responses. J Clin Oncoi 2012;30:1235-1241. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/22412138.
166. Jacobsen PB, Wagner LI. A new quality standard: the integration
of psychosocial care into routine cancer care. J Clin Oncol 
2012;30:1154-1159. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/22412134.
167. Jacobsen PB, Holland JC, Steensma DP. Caring for the whole 
patient: the science of psychosocial care. J Clin Oncol 2012;30:1151- 
1153. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22412125.
168. Stanton AL. What happens now? Psychosocial care for cancer 
survivors after medical treatment completion. J Clin Oncol 
2012;30:1215-1220. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22412133.
169. Zebrack B, Isaacson S. Psychosocial care of adolescent and 
young adult patients with cancer and survivors. J Clin Oncol 
2012;30:1221-1226. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22412147.
170. Northouse L, Williams AL, Given B, McCorkle R. Psychosocial 
care for family caregivers of patients with cancer. J Clin Oncol 
2012;30:1227-1234. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22412124.
Version 2.2013, 10/11/12 ©National Comprehensive Cancer Network, Inc. 2012, All rights reserved. The NCCN Guidelines© and this illustration may not be reproduced i r  any form  w ithou t the express w ritten  perm ission o f  N C C N ® .M S  - 2 8
130
131
Comprehensive Psychosocial Assessment Chart Audit Instrument 
Denise Sartz
Chart number: Date Enrolled in Project:
Appendix H
Demographics:
Gender: Male Female
Age:
Oncologist: Batezini El-Tarabily Other
Ethnicity: Caucasian African American Hispanic Asian Other
Language spoken: English Spanish Other
Marital status: Single Married Widowed Divorced
Employment status: Retired Full time Part time Unemployed Student Disabled
Primary care provider: Yes No
Insurance: Medicare Medicaid Private Uninsured
Living Situation: Alone Spouse Extended Family Non-relatives Assisted Living
Skilled Nursing Facility Other
Current Residence: Cheyenne Wheatland Torrington Kimball Laramie Other
Religion: Catholic LDS Presbyterian Lutheran Christian Jewish None Other
Diagnosis & Treatment History:
Cancer Diagnosis:
Date of Diagnosis: Month: Year:
Stage: I II III IV Unknown Not Applicable
Chemotherapy Treatment:
Treatment Goal: Palliative Curative Unknown
132
Line of Treatment: First Second Third Fourth Five or more
Concomitant Radiation: Yes No
Comorbid Conditions: CHF COPD DM CVA OA CAD Other
Baseline ECOG performance score: 0 1 2 3 4 Unknown
NCCN Distress Score:
Category: Practical Family Emotional Spiritual Physical
Date o f Score:
ECOG: 0 1 2  3 4 
Intervention:
NCCN Distress Score:
Category: Practical Family Emotional Spiritual Physical
Date o f Score:
ECOG: 0 1 2  3 4 
Intervention:
NCCN Distress Score:
Category: Practical Family Emotional Spiritual Physical
Date o f Score:
ECOG: 0 1 2  3 4 
Intervention:
NCCN Distress Score:
Category: Practical Family Emotional Spiritual Physical
Date o f Score:
ECOG: 0 1 2  3 4 
Intervention:
NCCN Distress Score:
Category: Practical Family Emotional Spiritual Physical
Date o f Score:
ECOG: 0 1 2  3 4 
Intervention:
NCCN Distress Score:
Category: Practical Family Emotional Spiritual Physical
Date o f Score:
ECOG: 0 1 2  3 4 
Intervention:
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Information and referral interventions provided after DT scores obtained:
HO: Handout (resources available in community) provided
R: Referral Options: Nurse Practitioner, Hospice, Lymphedema, Nutrition, Psych, Chaplain, Social Worker, 
Meals on Wheels, Patient Navigator, Financial Counselor, Palliative Care, Home Care, Wound Care, 
Oncologist, Primary Care Physician, PT/OT, Patient Refused Referral, Other
Emergency Room Visits During Treatment: Yes No
Dates (if applicable):__________________________________________________________________
Reason:_____________________________________________________________________________
Hospitalizations During Treatment: Yes No
Dates (if applicable):_________________________________________________________________
Admitting Diagnosis:_________________________________________________________________
Length o f Stay:______________________________________________________________________
Project Status: Completed Withdrawn by investigator Patient Withdrew Deceased 
Participation Completion D ate:________________________________________
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Completion Report Appendix I Page 1 of 1
CITI Collaborative Institutional Training Initiative
Human Research Curriculum Completion Report 
Printed on 7/31/2012
Learner: Denise Sartz (username: denisesartz) 
institution: Regis University
Contact Department: Nursing
Information Email: sartz158@regis.edu
Social Behavioral Research Investigators and Key Personnel:
Stage 1. Basic Course Passed on 07/31/12 (Ref # 8379770)
Required Modules
Date
Completed
Introduction 07/31/12 no quiz
History and Ethical Principles - SBR 07/31/12 4/5 (80%)
The Regulations and The Social and Behavioral 
Sciences - SBR
07/31 /12 5/5 (100%)
Assessing Risk in Social and Behavioral Sciences - 
SBR
07/31/12 5/5 (100%)
Informed Consent - SBR 07/31/12 5/5 (100%)
Privacy and Confidentiality - SBR 07/31/12 4/5 (80%)
Regis University 07/31 /12 no quiz
For th is Completion Report to be valid, the learner listed above must be 
affiliated w ith a CITI participating institution. Falsified information and 
unauthorized use o f the CITI course site is unethical, and may be 
considered scientific m isconduct by your institution.
Paul Braunschweiger Ph.D.
Professor, University of Miami 
Director Office o f Research Education 
CITI Course Coordinator
Return
https://www.citiprogram.org/members/leamersII/crbystage. asp ?strKeyID=0A3303 88-7106... 7/31/2012
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NEIRB
New England Institutional 
Review Board
A ppendix J
January 18, 2013
Denise A. Sartz, MS 
Cheyenne Regional Medical Center 
214 East 23rd Street 
Cheyenne, WY 82001
RE: NEIRB# 13-018: "Screening for Distress in Ambulatory Oncology Patients"
Dear Dr. Sartz:
This is to inform you that New England Institutional Review Board (NEIRB) has reviewed the submission for 
the above-captioned project.
NEIRB has determined that this activity, as conducted at the above location, is not seeking to obtain 
generalizable knowledge. Therefore, it is not human subjects research and IRB review and approval is not 
required.
Please call me if  you have any questions about the terms o f this determination
Erin Brower, MS, CIP 
Director
Copy: NEIRB Chair
85 Wells Avenue • Suite 107 ' Newton, MA 02459 Phone: 617-243-3924 * Fax:617-969-1310 www.neirb.com
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3333 Regis Boulevard, H-4 
Denver, Colorado 80221-1099
303-458-4206 
303-964-5528 FAX 
www.regis.edu
Appendix K 
IRB -  REGIS UNIVERSITY
February 18,2013
Denise Sartz
2718 Stockbury Drive
Fort Collins, CO 80525
RE: IRB#: 13-043
Dear Ms. Sartz:
Your application to the Regis IRB for your project “Screening for Distress in Ambulatory 
Oncology Patients: The COPE Project” was approved as an exempt study on February 13, 2013. 
This study was approved under the 45CFR46.101.b exempt study category #2.
The designation of “exempt,” means no further IRB review of this project, as it is currently 
designed, is needed.
If changes are made in the research plan that significantly alter the involvement of human 
subjects from that which was approved in the named application, the new research plan must be 
resubmitted to the Regis IRB for approval.
Sincerely,
Patsy McGuire Cullen, PhD, CPNP
Chair, Institutional Review Board
Associate Professor and Director
Department of Accelerated Nursing
Loretto Heights School of Nursing
Rueckert-Hartman College for Health Professions
Regis University
cc: Dr. Diane Ernst
A JESUIT UNIVERSITY
137
Appendix L
Cheyenne Regional 
Medical Center
214 East 23rd Street 
Cheyenne, WY 82001 
307'634-2273
January 21, 2013
Institutional Review Board 
Regis University
Main Hall, Room 452, Mail Code H4 
Denver, CO 80221 
Email: irb@regis.edu
RE: Denise Sartz, FNP-C, Doctoral Research 
To Whom It May Conccrn;
As the Chief Compliance and Privacy Officer, this letter is to serve as notice that Cheyenne 
Regional Medical Center supports the project proposed by Denise Sartz, FNP-C, entitled 
“Screening for Distress in Ambulatory Oncology Patients”. Cheyenne Regional is pleased to 
support Ms. Sartz in her academic endeavors and we anticipate the results of her research.
For this study, Cheyenne Regional understands that Ms. Sartz will have patients complete a 
short questionnaire during each chemotherapy visit and using that information, see if 
putting people in touch with resources will improve their overall well-being. This project 
has been approved by our outside Institutional Review Board, New England IRB. We 
anticipate that if the scope of the study is to change that Ms. Sartz uni I notify Cheyenne 
Regional in advance of the change to determine if additional institutional safe guards need 
to be followed.
If you have any additional questions or conccrns, please contact Aimee Dendrinos, 
Compliance Counsel at (307) 432-6624 or aimee.dendrinos@crmcwv.org.
Thank you,
Carlene Crall
Chief Human Resources Officer 
Chief Compliance Officer
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Appendix M 
Cheyenne Regional Medical Center 
Oncology Product Line 
Psychosocial Distress Screening Policy 
2012 Standard E10: Psychosocial Distress Screening 
Rationale:
Distress (defined): A multifactorial, unpleasant emotional experience o f a psychological 
(cognitive, behavioral, emotional), social and/or spiritual nature that may interfere with the 
ability to cope effectively with cancer, its physical symptoms and its treatment. Distress extends 
along a continuum, ranging from common normal feelings of vulnerability, sadness, and fears to 
problems that can become disabling, such as depression, anxiety, panic, social isolation, and 
existential and spiritual crisis (NCCN, 2012). Oncology patients frequently present with 
complex physical needs as well as overwhelming unmet psychosocial concerns. It has been 
estimated that 40-50% of adults with cancer experience clinically significant levels o f distress 
(Jacobsen, Donovan, and Trask, 2005). In addition, it has been demonstrated that patients with 
heightened distress have poorer treatment outcomes, poorer quality of life and overall poor 
satisfaction with care (Jacobsen & Ransom, 2007). In response to these needs the National 
Comprehensive Cancer Network (NCCN) issued evidenced-based guidelines to help clinicians 
identify, assess, and treat unmet spiritual, psychological, practical, and physical problems.
Policy:
As agreed upon by the Cheyenne Regional Medical Center Cancer Committee, oncology patients 
will be screened and assessed for distress utilizing the NCCN Distress Thermometer 
(Comprehensive Oncology Patient Experience (COPE) Tool).
All patients will be screened and assessed for distress at their initial visit, at appropriate intervals, 
and as clinically indicated, especially when changes occur in disease status (remission, 
recurrence, or progression). At a minimum, a baseline assessment will be completed prior to 
beginning chemotherapy/radiation therapy and again as deemed clinically necessary.
Procedure:
All oncology patients and their caregivers will be provided information about the psychosocial 
services available at Cheyenne Regional Medical Center and within the community.
Clinical evidence o f a moderate to severe distress score (>4) on the NCCN distress thermometer 
requires a clinical assessment by a member of the primary oncology team (oncologist, nurse 
practitioner, clinical nurse specialist, registered nurse, or social worker). Patients with a 
moderate to severe distress score will be referred to a mental health specialist, social worker, or 
chaplain depending on the problems identified on the problem list. Distress assessments, 
interventions, and referrals are documented in the patient medical record to facilitate integrated, 
high quality care by the multi-disciplinary team.
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Appendix N  
Electronic Health Record Integration
$ COPE Assessment - COPE Assessment Based on Past Week (To be completed monthly)
Time taken: 0810 7/18/2013
Responsible Create Note
v  Psychiatric
Distress
7^ Practical Problems
Child Care Q 1=Yes 2=No
Housing D l=Yes 2=No
insurance 1 Financial D 1=Yes 2=No
Transportation D 1=Yes 2=No
W ork/School D 1=Yes 2=No
Treatment Decisions 0 1=Yes 2=No
Family Problems
Dealing with children D 1=Yes 2=No
Dealing with partner D 1=Yes 2=No
Ability to have D 1=Yes 2=No
children
Family health issues D 1=Yes 2=No
